Detail Information of Exogenous Modulation
| General Information of Drug Transporter (DT) | |||||
|---|---|---|---|---|---|
| DT ID | DTD0003 Transporter Info | ||||
| Gene Name | ABCB1 | ||||
| Transporter Name | P-glycoprotein 1 | ||||
| Gene ID | |||||
| UniProt ID | |||||
| Exogenous factors (drugs, dietary constituents, etc.) Modulation of This DT (EGM) | |||||
|---|---|---|---|---|---|
Approved Drug |
|||||
Cyclosporine |
34 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Cyclosporine inhibits the transportation of Calcein AM by ABCB1 (Ki = 1.8 microM) | [1] | |||
Affected Drug/Substrate |
Calcein AM | Modulation Type | Inhibition | ||
Cell System |
CEM/VLB100 drug-resistant cells-MDR1 | ||||
DT Modulation 2 |
Cyclosporine inhibits the transportation of Calcein AM by ABCB1 (IC50 = 3.41 microM) | [2] | |||
Affected Drug/Substrate |
Calcein AM | Modulation Type | Inhibition | ||
Cell System |
CEM/VLB100 drug-resistant cells-MDR1 | ||||
DT Modulation 3 |
Cyclosporine inhibits the transportation of Calcein AM by ABCB1 (IC50 = 1.7 microM) | [3] | |||
Affected Drug/Substrate |
Calcein AM | Modulation Type | Inhibition | ||
Cell System |
NIH-3T3-G185-MDR1 | ||||
DT Modulation 4 |
Cyclosporine inhibits the transportation of Calcein AM by ABCB1 (Ki = 4.66 microM) | [4] | |||
Affected Drug/Substrate |
Calcein AM | Modulation Type | Inhibition | ||
Cell System |
LLC-PK1 vesicles-MDR1 | ||||
DT Modulation 5 |
Cyclosporine inhibits the transportation of Calcein AM by ABCB1 (IC50 = 0.8 microM) | [5] | |||
Affected Drug/Substrate |
Calcein AM | Modulation Type | Inhibition | ||
Cell System |
LLC-PK1 vesicles-MDR1 | ||||
DT Modulation 6 |
Cyclosporine inhibits the transportation of Colchicine by ABCB1 (IC50 = 1.36 microM) | [6] | |||
Affected Drug/Substrate |
Colchicine | Modulation Type | Inhibition | ||
Cell System |
Madin Darby canine kidney strain II (MDCKII) cells-MDR1 | ||||
DT Modulation 7 |
Cyclosporine inhibits the transportation of Daunorubicin by ABCB1 (IC50 = 1.4 microM) | [3] | |||
Affected Drug/Substrate |
Daunorubicin | Modulation Type | Inhibition | ||
Cell System |
NIH-3T3-G185-MDR1 | ||||
DT Modulation 8 |
Cyclosporine inhibits the transportation of Digoxin by ABCB1 (Ki = 0.46 microM) | [7] | |||
Affected Drug/Substrate |
Digoxin | Modulation Type | Inhibition | ||
Cell System |
Human enterocyte-like 2 cell (Caco-2)-MDR1 | ||||
DT Modulation 9 |
Cyclosporine inhibits the transportation of Digoxin by ABCB1 (IC50 = 1.3 microM) | [8] | |||
Affected Drug/Substrate |
Digoxin | Modulation Type | Inhibition | ||
Cell System |
Human enterocyte-like 2 cell (Caco-2)-MDR1 | ||||
DT Modulation 10 |
Cyclosporine inhibits the transportation of Digoxin by ABCB1 (Ki = 0.35 +/- 0.04 microM) | [9] | |||
Affected Drug/Substrate |
Digoxin | Modulation Type | Inhibition | ||
Cell System |
Human enterocyte-like 2 cell (Caco-2)-MDR1 | ||||
DT Modulation 11 |
Cyclosporine inhibits the transportation of Digoxin by ABCB1 (IC50 = 1.6 microM) | [6] | |||
Affected Drug/Substrate |
Digoxin | Modulation Type | Inhibition | ||
Cell System |
Madin Darby canine kidney strain II (MDCKII) cells-MDR1 | ||||
DT Modulation 12 |
Cyclosporine inhibits the transportation of Doxorubicin by ABCB1 (IC50 = 3.66 microM) | [10] | |||
Affected Drug/Substrate |
Doxorubicin | Modulation Type | Inhibition | ||
Cell System |
LLC-PK1 vesicles-MDR1 | ||||
DT Modulation 13 |
Cyclosporine inhibits the transportation of Fluo-3-AM by ABCB1 (IC50 = 2.4 microM) | [3] | |||
Affected Drug/Substrate |
Fluo-3-AM | Modulation Type | Inhibition | ||
Cell System |
NIH-3T3-G185-MDR1 | ||||
DT Modulation 14 |
Cyclosporine inhibits the transportation of LDS-751 by ABCB1 (IC50 = 1.8 microM) | [3] | |||
Affected Drug/Substrate |
LDS-751 | Modulation Type | Inhibition | ||
Cell System |
NIH-3T3-G185-MDR1 | ||||
DT Modulation 15 |
Cyclosporine inhibits the transportation of Rhodamine 123 by ABCB1 (IC50 = 1.4 microM) | [11] | |||
Affected Drug/Substrate |
Rhodamine 123 | Modulation Type | Inhibition | ||
Cell System |
NIH-3T3-G185-MDR1 | ||||
DT Modulation 16 |
Cyclosporine inhibits the transportation of Rhodamine 123 by ABCB1 (IC50 = 1.7 microM) | [3] | |||
Affected Drug/Substrate |
Rhodamine 123 | Modulation Type | Inhibition | ||
Cell System |
NIH-3T3-G185-MDR1 | ||||
DT Modulation 17 |
Cyclosporine inhibits the transportation of Tetramethylrosamine by ABCB1 (IC50 = 2.1 microM) | [3] | |||
Affected Drug/Substrate |
Tetramethylrosamine | Modulation Type | Inhibition | ||
Cell System |
NIH-3T3-G185-MDR1 | ||||
DT Modulation 18 |
Cyclosporine inhibits the transportation of Verapamil by ABCB1 (Ki = 0.02 microM) | [12] | |||
Affected Drug/Substrate |
Verapamil | Modulation Type | Inhibition | ||
Cell System |
Spodoptera frugiperda (Sf9) cells-MDR1 | ||||
DT Modulation 19 |
Cyclosporine inhibits the transportation of Vinblastine by ABCB1 (Ki = 1.3 microM) | [4] | |||
Affected Drug/Substrate |
Vinblastine | Modulation Type | Inhibition | ||
Cell System |
LLC-PK1 vesicles-MDR1 | ||||
DT Modulation 20 |
Cyclosporine inhibits the transportation of Vinblastine by ABCB1 (IC50 = 6.18 microM) | [6] | |||
Affected Drug/Substrate |
Vinblastine | Modulation Type | Inhibition | ||
Cell System |
Madin Darby canine kidney strain II (MDCKII) cells-MDR1 | ||||
DT Modulation 21 |
Cyclosporine inhibits the transportation of Calcein AM by ABCB1 | [13] , [14] | |||
Affected Drug/Substrate |
Calcein AM | Modulation Type | Inhibition | ||
Cell System |
Doxorubicin resistant A2780adr cell lines-MDR1 | ||||
DT Modulation 22 |
Cyclosporine inhibits the transportation of Colchicine by ABCB1 | [15] | |||
Affected Drug/Substrate |
Colchicine | Modulation Type | Inhibition | ||
Cell System |
Human T-cell line (CEM)/Tumour cell line-MDR1 | ||||
DT Modulation 23 |
Cyclosporine inhibits the transportation of Doxorubicin by ABCB1 | [16] | |||
Affected Drug/Substrate |
Doxorubicin | Modulation Type | Inhibition | ||
Cell System |
Myelogenous leukemia cell line (K562)-MDR1 | ||||
DT Modulation 24 |
Cyclosporine inhibits the transportation of Imatinib by ABCB1 | [17] | |||
Affected Drug/Substrate |
Imatinib | Modulation Type | Inhibition | ||
Cell System |
LLC-PK1 vesicles-MDR1 | ||||
DT Modulation 25 |
Cyclosporine inhibits the transportation of Indinavir by ABCB1 | [18] | |||
Affected Drug/Substrate |
Indinavir | Modulation Type | Inhibition | ||
Cell System |
Human enterocyte-like 2 cell (Caco-2)-MDR1 | ||||
DT Modulation 26 |
Cyclosporine inhibits the transportation of Propranolol by ABCB1 | [19] | |||
Affected Drug/Substrate |
Propranolol | Modulation Type | Inhibition | ||
Cell System |
Human enterocyte-like 2 cell (Caco-2)-MDR1 | ||||
DT Modulation 27 |
Cyclosporine inhibits the transportation of Rhodamine 123 by ABCB1 | [20] | |||
Affected Drug/Substrate |
Rhodamine 123 | Modulation Type | Inhibition | ||
Cell System |
Human ileocecal adenocarcinoma cell lines (HCT-8)-MDR1 | ||||
DT Modulation 28 |
Cyclosporine inhibits the transportation of Rhodamine 123 by ABCB1 | [21] | |||
Affected Drug/Substrate |
Rhodamine 123 | Modulation Type | Inhibition | ||
Cell System |
Mouse T-lymphoma L5178-MDR1 | ||||
DT Modulation 29 |
Cyclosporine inhibits the transportation of Saquinavir by ABCB1 | [20] | |||
Affected Drug/Substrate |
Saquinavir | Modulation Type | Inhibition | ||
Cell System |
Human ileocecal adenocarcinoma cell lines (HCT-8)-MDR1 | ||||
DT Modulation 30 |
Cyclosporine inhibits the transportation of Saquinavir by ABCB1 | [22] | |||
Affected Drug/Substrate |
Saquinavir | Modulation Type | Inhibition | ||
Cell System |
LLC-PK1 porcine kidney epithelial (LLC-GA5-COL150) cells-MDR1 | ||||
DT Modulation 31 |
Cyclosporine inhibits the transportation of JC-1 by ABCB1 | [23] | |||
Affected Drug/Substrate |
JC-1 | Modulation Type | Inhibition | ||
DT Modulation 32 |
Cyclosporine inhibits the transportation of Vinblastine by ABCB1 | [24] | |||
Affected Drug/Substrate |
Vinblastine | Modulation Type | Inhibition | ||
DT Modulation 33 |
Cyclosporine inhibits the activity of ABCB1 | [25] | |||
Cell System |
Human enterocyte-like 2 cell (Caco-2)-MDR1 | ||||
DT Modulation 34 |
Cyclosporine induces the activity of ABCB1 | [26] , [27] | |||
Verapamil |
19 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Verapamil inhibits the transportation of Colchicine by ABCB1 (IC50 = 17.3 microM) | [6] | |||
Affected Drug/Substrate |
Colchicine | Modulation Type | Inhibition | ||
Cell System |
Madin Darby canine kidney strain II (MDCKII) cells-MDR1 | ||||
DT Modulation 2 |
Verapamil inhibits the transportation of Digoxin by ABCB1 (Ki = 15.1 microM) | [7] | |||
Affected Drug/Substrate |
Digoxin | Modulation Type | Inhibition | ||
Cell System |
Madin-Darby Canine Kidney (MDCK) cells-MDR1 | ||||
DT Modulation 3 |
Verapamil inhibits the transportation of Digoxin by ABCB1 (Ki = 8.11 microM) | [7] | |||
Affected Drug/Substrate |
Digoxin | Modulation Type | Inhibition | ||
Cell System |
Human enterocyte-like 2 cell (Caco-2)-MDR1 | ||||
DT Modulation 4 |
Verapamil inhibits the transportation of Digoxin by ABCB1 (IC50 = 10.7 microM) | [6] | |||
Affected Drug/Substrate |
Digoxin | Modulation Type | Inhibition | ||
Cell System |
Madin Darby canine kidney strain II (MDCKII) cells-MDR1 | ||||
DT Modulation 5 |
Verapamil inhibits the transportation of Fexofenadine by ABCB1 (IC50 = 8.44 microM) | [28] | |||
Affected Drug/Substrate |
Fexofenadine | Modulation Type | Inhibition | ||
Cell System |
Human enterocyte-like 2 cell (Caco-2)-MDR1 | ||||
DT Modulation 6 |
Verapamil inhibits the transportation of Irinotecan by ABCB1 (Ki = 29 microM) | [29] | |||
Affected Drug/Substrate |
Irinotecan | Modulation Type | Inhibition | ||
Cell System |
Madin Darby canine kidney strain II (MDCKII) cells-MDR1 | ||||
DT Modulation 7 |
Verapamil inhibits the transportation of Paclitaxel by ABCB1 (IC50 = 4.78 microM) | [30] | |||
Affected Drug/Substrate |
Paclitaxel | Modulation Type | Inhibition | ||
Cell System |
Human uterine cancer cells (MES-SA/Dx5) | ||||
DT Modulation 8 |
Verapamil inhibits the transportation of Rhodamine 123 by ABCB1 (IC50 = 4.2 microM) | [11] | |||
Affected Drug/Substrate |
Rhodamine 123 | Modulation Type | Inhibition | ||
Cell System |
NIH-3T3-G185-MDR1 | ||||
DT Modulation 9 |
Verapamil inhibits the transportation of Vinblastine by ABCB1 (IC50 = 33.5 microM) | [6] | |||
Affected Drug/Substrate |
Vinblastine | Modulation Type | Inhibition | ||
Cell System |
Madin Darby canine kidney strain II (MDCKII) cells-MDR1 | ||||
DT Modulation 10 |
Verapamil inhibits the transportation of Vincristine by ABCB1 (IC50 = 0.2 microM) | [31] | |||
Affected Drug/Substrate |
Vincristine | Modulation Type | Inhibition | ||
Cell System |
Myelogenous leukemia cell line (K562)-MDR1 | ||||
DT Modulation 11 |
Verapamil inhibits the transportation of Paclitaxel by ABCB1 (IC50 = 2.21 microM) | [30] | |||
Affected Drug/Substrate |
Paclitaxel | Modulation Type | Inhibition | ||
DT Modulation 12 |
Verapamil inhibits the transportation of Calcein by ABCB1 | [32] | |||
Affected Drug/Substrate |
Calcein | Modulation Type | Inhibition | ||
Cell System |
Adriamycin-Resistant Human Ovarian Cancer A2780 cells-MDR1 | ||||
DT Modulation 13 |
Verapamil inhibits the transportation of Calcein AM by ABCB1 | [33] | |||
Affected Drug/Substrate |
Calcein AM | Modulation Type | Inhibition | ||
Cell System |
Human colon cancer cell lines (HCT-15)-MDR1 | ||||
DT Modulation 14 |
Verapamil inhibits the transportation of Daunomycin by ABCB1 | [34] | |||
Affected Drug/Substrate |
Daunomycin | Modulation Type | Inhibition | ||
Cell System |
NIH 3T3 cells-MDR1 | ||||
DT Modulation 15 |
Verapamil inhibits the transportation of Digoxin by ABCB1 | [35] | |||
Affected Drug/Substrate |
Digoxin | Modulation Type | Inhibition | ||
Cell System |
Human enterocyte-like 2 cell (Caco-2)-MDR1 | ||||
DT Modulation 16 |
Verapamil inhibits the transportation of Rhodamine 123 by ABCB1 | [36] | |||
Affected Drug/Substrate |
Rhodamine 123 | Modulation Type | Inhibition | ||
Cell System |
Madin-Darby Canine Kidney (MDCK) cells-MDR1 | ||||
DT Modulation 17 |
Verapamil inhibits the transportation of Adriamycin by ABCB1 | [37] , [38] , [39] | |||
Affected Drug/Substrate |
Adriamycin | Modulation Type | Inhibition | ||
DT Modulation 18 |
Verapamil inhibits the transportation of Doxorubicin by ABCB1 | [40] , [39] | |||
Affected Drug/Substrate |
Doxorubicin | Modulation Type | Inhibition | ||
DT Modulation 19 |
Verapamil inhibits the activity of ABCB1 | [41] , [40] | |||
Quinine |
9 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Quinine inhibits the transportation of Colchicine by ABCB1 (IC50 = 51.7 microM) | [6] | |||
Affected Drug/Substrate |
Colchicine | Modulation Type | Inhibition | ||
Cell System |
Madin Darby canine kidney strain II (MDCKII) cells-MDR1 | ||||
DT Modulation 2 |
Quinine inhibits the transportation of Digoxin by ABCB1 (Ki = 8.59 microM) | [7] | |||
Affected Drug/Substrate |
Digoxin | Modulation Type | Inhibition | ||
Cell System |
Madin-Darby Canine Kidney (MDCK) cells-MDR1 | ||||
DT Modulation 3 |
Quinine inhibits the transportation of Digoxin by ABCB1 (Ki = 3.23 microM) | [7] | |||
Affected Drug/Substrate |
Digoxin | Modulation Type | Inhibition | ||
Cell System |
Human enterocyte-like 2 cell (Caco-2)-MDR1 | ||||
DT Modulation 4 |
Quinine inhibits the transportation of Digoxin by ABCB1 (IC50 = 9.52 microM) | [49] | |||
Affected Drug/Substrate |
Digoxin | Modulation Type | Inhibition | ||
Cell System |
LLC-PK1 vesicles-MDR1 | ||||
DT Modulation 5 |
Quinine inhibits the transportation of Digoxin by ABCB1 (IC50 = 22.4 microM) | [50] | |||
Affected Drug/Substrate |
Digoxin | Modulation Type | Inhibition | ||
Cell System |
Madin Darby canine kidney strain II (MDCKII) cells-MDR1 | ||||
DT Modulation 6 |
Quinine inhibits the transportation of Digoxin by ABCB1 (IC50 = 9.4 microM) | [50] | |||
Affected Drug/Substrate |
Digoxin | Modulation Type | Inhibition | ||
Cell System |
Madin Darby canine kidney strain II (MDCKII) cells-MDR1 | ||||
DT Modulation 7 |
Quinine inhibits the transportation of Digoxin by ABCB1 (IC50 = 14.9 microM) | [6] | |||
Affected Drug/Substrate |
Digoxin | Modulation Type | Inhibition | ||
Cell System |
Madin Darby canine kidney strain II (MDCKII) cells-MDR1 | ||||
DT Modulation 8 |
Quinine inhibits the transportation of Vinblastine by ABCB1 (IC50 = 22.9 microM) | [6] | |||
Affected Drug/Substrate |
Vinblastine | Modulation Type | Inhibition | ||
Cell System |
Madin Darby canine kidney strain II (MDCKII) cells-MDR1 | ||||
DT Modulation 9 |
Quinine inhibits the transportation of Rhodamine 123 by ABCB1 | [21] | |||
Affected Drug/Substrate |
Rhodamine 123 | Modulation Type | Inhibition | ||
Cell System |
Mouse T-lymphoma L5178-MDR1 | ||||
Troleandomycin |
5 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Troleandomycin inhibits the transportation of Calcein AM by ABCB1 (Ki = 483.3 microM) | [4] | |||
Affected Drug/Substrate |
Calcein AM | Modulation Type | Inhibition | ||
Cell System |
LLC-PK1 vesicles-MDR1 | ||||
DT Modulation 2 |
Troleandomycin inhibits the transportation of Daunorubicin by ABCB1 (IC50 = 68.3 microM) | [3] | |||
Affected Drug/Substrate |
Daunorubicin | Modulation Type | Inhibition | ||
Cell System |
NIH-3T3-G185-MDR1 | ||||
DT Modulation 3 |
Troleandomycin inhibits the transportation of LDS-751 by ABCB1 (IC50 = 78.2 microM) | [3] | |||
Affected Drug/Substrate |
LDS-751 | Modulation Type | Inhibition | ||
Cell System |
NIH-3T3-G185-MDR1 | ||||
DT Modulation 4 |
Troleandomycin inhibits the transportation of Rhodamine 123 by ABCB1 (IC50 = 86.3 microM) | [3] | |||
Affected Drug/Substrate |
Rhodamine 123 | Modulation Type | Inhibition | ||
Cell System |
NIH-3T3-G185-MDR1 | ||||
DT Modulation 5 |
Troleandomycin inhibits the transportation of Vinblastine by ABCB1 (Ki = 87.64 microM) | [4] | |||
Affected Drug/Substrate |
Vinblastine | Modulation Type | Inhibition | ||
Cell System |
LLC-PK1 vesicles-MDR1 | ||||
Lovastatin |
6 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Lovastatin inhibits the transportation of Calcein AM by ABCB1 (IC50 = 10 +/- 4 microM) | [53] | |||
Affected Drug/Substrate |
Calcein AM | Modulation Type | Inhibition | ||
Cell System |
Madin-Darby Canine Kidney (MDCK) cells-MDR1 | ||||
DT Modulation 2 |
Lovastatin inhibits the transportation of LDS-751 by ABCB1 (IC50 = 32.7 microM) | [3] | |||
Affected Drug/Substrate |
LDS-751 | Modulation Type | Inhibition | ||
Cell System |
NIH-3T3-G185-MDR1 | ||||
DT Modulation 3 |
Lovastatin inhibits the transportation of Rhodamine 123 by ABCB1 (IC50 = 114.4 microM) | [3] | |||
Affected Drug/Substrate |
Rhodamine 123 | Modulation Type | Inhibition | ||
Cell System |
NIH-3T3-G185-MDR1 | ||||
DT Modulation 4 |
Lovastatin inhibits the transportation of Daunorubicin by ABCB1 (IC50 = 26 microM) | [54] | |||
Affected Drug/Substrate |
Daunorubicin | Modulation Type | Inhibition | ||
DT Modulation 5 |
Lovastatin inhibits the transportation of Rhodamine 123 by ABCB1 (IC50 = 67 microM) | [54] | |||
Affected Drug/Substrate |
Rhodamine 123 | Modulation Type | Inhibition | ||
DT Modulation 6 |
Lovastatin inhibits the transportation of Digoxin by ABCB1 | [57] | |||
Affected Drug/Substrate |
Digoxin | Modulation Type | Inhibition | ||
Cell System |
Human enterocyte-like 2 cell (Caco-2)-MDR1 | ||||
Vinblastine |
6 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Vinblastine inhibits the transportation of Calcein AM by ABCB1 (IC50 = 29 microM) | [53] | |||
Affected Drug/Substrate |
Calcein AM | Modulation Type | Inhibition | ||
Cell System |
Madin-Darby Canine Kidney (MDCK) cells-MDR1 | ||||
DT Modulation 2 |
Vinblastine inhibits the transportation of Colchicine by ABCB1 (IC50 = 30.1 microM) | [6] | |||
Affected Drug/Substrate |
Colchicine | Modulation Type | Inhibition | ||
Cell System |
Madin Darby canine kidney strain II (MDCKII) cells-MDR1 | ||||
DT Modulation 3 |
Vinblastine inhibits the transportation of Digoxin by ABCB1 (IC50 = 17.8 microM) | [6] | |||
Affected Drug/Substrate |
Digoxin | Modulation Type | Inhibition | ||
Cell System |
Madin Darby canine kidney strain II (MDCKII) cells-MDR1 | ||||
DT Modulation 4 |
Vinblastine inhibits the transportation of Rhodamine 123 by ABCB1 (IC50 = 18 microM) | [11] | |||
Affected Drug/Substrate |
Rhodamine 123 | Modulation Type | Inhibition | ||
Cell System |
NIH-3T3-G185-MDR1 | ||||
DT Modulation 5 |
Vinblastine inhibits the transportation of Vinblastine by ABCB1 (IC50 = 89.7 microM) | [6] | |||
Affected Drug/Substrate |
Vinblastine | Modulation Type | Inhibition | ||
Cell System |
Madin Darby canine kidney strain II (MDCKII) cells-MDR1 | ||||
DT Modulation 6 |
Vinblastine inhibits the transportation of Rhodamine 123 by ABCB1 | [36] | |||
Affected Drug/Substrate |
Rhodamine 123 | Modulation Type | Inhibition | ||
Cell System |
Madin-Darby Canine Kidney (MDCK) cells-MDR1 | ||||
Ketoconazole |
6 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Ketoconazole inhibits the transportation of Colchicine by ABCB1 (IC50 = 5.49 microM) | [6] | |||
Affected Drug/Substrate |
Colchicine | Modulation Type | Inhibition | ||
Cell System |
Madin Darby canine kidney strain II (MDCKII) cells-MDR1 | ||||
DT Modulation 2 |
Ketoconazole inhibits the transportation of Digoxin by ABCB1 (IC50 = 1.34 microM) | [50] | |||
Affected Drug/Substrate |
Digoxin | Modulation Type | Inhibition | ||
Cell System |
Madin Darby canine kidney strain II (MDCKII) cells-MDR1 | ||||
DT Modulation 3 |
Ketoconazole inhibits the transportation of Digoxin by ABCB1 (IC50 = 3.07 microM) | [6] | |||
Affected Drug/Substrate |
Digoxin | Modulation Type | Inhibition | ||
Cell System |
Madin Darby canine kidney strain II (MDCKII) cells-MDR1 | ||||
DT Modulation 4 |
Ketoconazole inhibits the transportation of Rhodamine 123 by ABCB1 (IC50 = 5.6 microM) | [11] | |||
Affected Drug/Substrate |
Rhodamine 123 | Modulation Type | Inhibition | ||
Cell System |
NIH-3T3-G185-MDR1 | ||||
DT Modulation 5 |
Ketoconazole inhibits the transportation of Vinblastine by ABCB1 (IC50 = 6.34 microM) | [6] | |||
Affected Drug/Substrate |
Vinblastine | Modulation Type | Inhibition | ||
Cell System |
Madin Darby canine kidney strain II (MDCKII) cells-MDR1 | ||||
DT Modulation 6 |
Ketoconazole inhibits the activity of ABCB1 | [58] | |||
Cell System |
Human enterocyte-like 2 cell (Caco-2)-MDR1 | ||||
Progesterone |
6 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Progesterone inhibits the transportation of Daunorubicin by ABCB1 (IC50 = 96.2 microM) | [3] | |||
Affected Drug/Substrate |
Daunorubicin | Modulation Type | Inhibition | ||
Cell System |
NIH-3T3-G185-MDR1 | ||||
DT Modulation 2 |
Progesterone inhibits the transportation of LDS-751 by ABCB1 (IC50 = 88.1 microM) | [3] | |||
Affected Drug/Substrate |
LDS-751 | Modulation Type | Inhibition | ||
Cell System |
NIH-3T3-G185-MDR1 | ||||
DT Modulation 3 |
Progesterone inhibits the transportation of Rhodamine 123 by ABCB1 (IC50 = 192.2 microM) | [3] | |||
Affected Drug/Substrate |
Rhodamine 123 | Modulation Type | Inhibition | ||
Cell System |
NIH-3T3-G185-MDR1 | ||||
DT Modulation 4 |
Progesterone inhibits the transportation of Calcein AM by ABCB1 | [55] | |||
Affected Drug/Substrate |
Calcein AM | Modulation Type | Inhibition | ||
Cell System |
NIH 3T3 cells-MDR1 | ||||
DT Modulation 5 |
Progesterone inhibits the transportation of Cortisol by ABCB1 | [56] | |||
Affected Drug/Substrate |
Cortisol | Modulation Type | Inhibition | ||
Cell System |
LLC-PK1 vesicles-MDR1 | ||||
DT Modulation 6 |
Progesterone inhibits the transportation of Vinblastine by ABCB1 | [24] | |||
Affected Drug/Substrate |
Vinblastine | Modulation Type | Inhibition | ||
Etoposide |
5 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Etoposide inhibits the transportation of Calcein AM by ABCB1 (IC50 = 50 microM) | [5] | |||
Affected Drug/Substrate |
Calcein AM | Modulation Type | Inhibition | ||
Cell System |
LLC-PK1 vesicles-MDR1 | ||||
DT Modulation 2 |
Etoposide inhibits the transportation of Digoxin by ABCB1 (Ki = 768 microM) | [7] | |||
Affected Drug/Substrate |
Digoxin | Modulation Type | Inhibition | ||
Cell System |
Madin-Darby Canine Kidney (MDCK) cells-MDR1 | ||||
DT Modulation 3 |
Etoposide inhibits the transportation of Taxol by ABCB1 (Ki = 276 microM) | [25] | |||
Affected Drug/Substrate |
Taxol | Modulation Type | Inhibition | ||
Cell System |
Human enterocyte-like 2 cell (Caco-2)-MDR1 | ||||
DT Modulation 4 |
Etoposide inhibits the transportation of Rhodamine 123 by ABCB1 | [5] | |||
Affected Drug/Substrate |
Rhodamine 123 | Modulation Type | Inhibition | ||
Cell System |
Human enterocyte-like 2 cell (Caco-2)-MDR1 | ||||
DT Modulation 5 |
Etoposide induces the activity of ABCB1 | [69] | |||
Reserpine |
4 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Reserpine inhibits the transportation of Digoxin by ABCB1 (Ki = 1.38 microM) | [7] | |||
Affected Drug/Substrate |
Digoxin | Modulation Type | Inhibition | ||
Cell System |
Human enterocyte-like 2 cell (Caco-2)-MDR1 | ||||
DT Modulation 2 |
Reserpine inhibits the transportation of Rhodamine 123 by ABCB1 | [60] , [61] | |||
Affected Drug/Substrate |
Rhodamine 123 | Modulation Type | Inhibition | ||
Cell System |
Human breast adenocarcinoma cell line (MCF-7)-MDR1 | ||||
DT Modulation 3 |
Reserpine induces the activity of ABCB1 | [66] | |||
Cell System |
Human colon carcinoma cell lines (LS174T)-MDR1 | ||||
DT Modulation 4 |
Reserpine inhibits the activity of ABCB1 | [70] , [71] | |||
Miconazole |
4 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Miconazole inhibits the transportation of Calcein AM by ABCB1 (Ki = 55.5 microM) | [4] | |||
Affected Drug/Substrate |
Calcein AM | Modulation Type | Inhibition | ||
Cell System |
LLC-PK1 vesicles-MDR1 | ||||
DT Modulation 2 |
Miconazole inhibits the transportation of Calcein AM by ABCB1 (IC50 = 3.5 microM) | [5] | |||
Affected Drug/Substrate |
Calcein AM | Modulation Type | Inhibition | ||
Cell System |
LLC-PK1 vesicles-MDR1 | ||||
DT Modulation 3 |
Miconazole inhibits the transportation of Vinblastine by ABCB1 (Ki = 26.36 microM) | [4] | |||
Affected Drug/Substrate |
Vinblastine | Modulation Type | Inhibition | ||
Cell System |
LLC-PK1 vesicles-MDR1 | ||||
DT Modulation 4 |
Miconazole inhibits the transportation of Rhodamine 123 by ABCB1 | [5] | |||
Affected Drug/Substrate |
Rhodamine 123 | Modulation Type | Inhibition | ||
Cell System |
Human enterocyte-like 2 cell (Caco-2)-MDR1 | ||||
Trifluoperazine |
4 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Trifluoperazine inhibits the transportation of Daunorubicin by ABCB1 (IC50 = 7.2 microM) | [3] | |||
Affected Drug/Substrate |
Daunorubicin | Modulation Type | Inhibition | ||
Cell System |
NIH-3T3-G185-MDR1 | ||||
DT Modulation 2 |
Trifluoperazine inhibits the transportation of LDS-751 by ABCB1 (IC50 = 6.3 microM) | [3] | |||
Affected Drug/Substrate |
LDS-751 | Modulation Type | Inhibition | ||
Cell System |
NIH-3T3-G185-MDR1 | ||||
DT Modulation 3 |
Trifluoperazine inhibits the transportation of Rhodamine 123 by ABCB1 (IC50 = 10.9 microM) | [3] | |||
Affected Drug/Substrate |
Rhodamine 123 | Modulation Type | Inhibition | ||
Cell System |
NIH-3T3-G185-MDR1 | ||||
DT Modulation 4 |
Trifluoperazine inhibits the activity of ABCB1 | [77] | |||
Ritonavir |
4 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Ritonavir inhibits the transportation of Digoxin by ABCB1 (IC50 = 3.8 microM) | [8] | |||
Affected Drug/Substrate |
Digoxin | Modulation Type | Inhibition | ||
Cell System |
Human enterocyte-like 2 cell (Caco-2)-MDR1 | ||||
DT Modulation 2 |
Ritonavir inhibits the transportation of Digoxin by ABCB1 (IC50 = 28.2 microM) | [50] | |||
Affected Drug/Substrate |
Digoxin | Modulation Type | Inhibition | ||
Cell System |
Madin Darby canine kidney strain II (MDCKII) cells-MDR1 | ||||
DT Modulation 3 |
Ritonavir inhibits the transportation of Digoxin by ABCB1 (IC50 = 5 microM) | [73] | |||
Affected Drug/Substrate |
Digoxin | Modulation Type | Inhibition | ||
Cell System |
Human enterocyte-like 2 cell (Caco-2)-MDR1 | ||||
DT Modulation 4 |
Ritonavir induces the activity of ABCB1 | [76] | |||
Erythromycin |
4 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Erythromycin inhibits the transportation of Digoxin by ABCB1 (IC50 = 10 microM) | [4] | |||
Affected Drug/Substrate |
Digoxin | Modulation Type | Inhibition | ||
Cell System |
Human enterocyte-like 2 cell (Caco-2)-MDR1 | ||||
DT Modulation 2 |
Erythromycin inhibits the transportation of Digoxin by ABCB1 (IC50 = 22.7 microM) | [72] | |||
Affected Drug/Substrate |
Digoxin | Modulation Type | Inhibition | ||
Cell System |
Human enterocyte-like 2 cell (Caco-2)-MDR1 | ||||
DT Modulation 3 |
Erythromycin inhibits the transportation of Ximelagatran by ABCB1 (IC50 = 119 microM) | [74] | |||
Affected Drug/Substrate |
Ximelagatran | Modulation Type | Inhibition | ||
Cell System |
Human enterocyte-like 2 cell (Caco-2)-MDR1 | ||||
DT Modulation 4 |
Erythromycin induces the activity of ABCB1 | [75] | |||
Bromocriptine |
3 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Bromocriptine inhibits the transportation of Calcein AM by ABCB1 (Ki = 2.81 microM) | [4] | |||
Affected Drug/Substrate |
Calcein AM | Modulation Type | Inhibition | ||
Cell System |
LLC-PK1 vesicles-MDR1 | ||||
DT Modulation 2 |
Bromocriptine inhibits the transportation of Vinblastine by ABCB1 (Ki = 3.96 microM) | [4] | |||
Affected Drug/Substrate |
Vinblastine | Modulation Type | Inhibition | ||
Cell System |
LLC-PK1 vesicles-MDR1 | ||||
DT Modulation 3 |
Bromocriptine inhibits the activity of ABCB1 | [86] | |||
Nifedipine |
3 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Nifedipine inhibits the transportation of Daunorubicin by ABCB1 (IC50 = 113 microM) | [78] | |||
Affected Drug/Substrate |
Daunorubicin | Modulation Type | Inhibition | ||
Cell System |
NIH-3T3-G185-MDR1 | ||||
DT Modulation 2 |
Nifedipine inhibits the transportation of Digoxin by ABCB1 (IC50 = 472 microM) | [80] | |||
Affected Drug/Substrate |
Digoxin | Modulation Type | Inhibition | ||
Cell System |
LLC-PK1 vesicles-MDR1 | ||||
DT Modulation 3 |
Nifedipine induces the activity of ABCB1 | [66] | |||
Cell System |
Human colon carcinoma cell lines (LS174T)-MDR1 | ||||
Amiodarone |
3 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Amiodarone inhibits the transportation of Daunorubicin by ABCB1 (IC50 = 22.5 microM) | [79] | |||
Affected Drug/Substrate |
Daunorubicin | Modulation Type | Inhibition | ||
Cell System |
LLC-PK1 vesicles-MDR1 | ||||
DT Modulation 2 |
Amiodarone inhibits the transportation of Digoxin by ABCB1 (IC50 = 45.6 microM) | [79] | |||
Affected Drug/Substrate |
Digoxin | Modulation Type | Inhibition | ||
Cell System |
LLC-PK1 vesicles-MDR1 | ||||
DT Modulation 3 |
Amiodarone inhibits the transportation of Digoxin by ABCB1 (IC50 = 5.48 microM) | [49] | |||
Affected Drug/Substrate |
Digoxin | Modulation Type | Inhibition | ||
Cell System |
LLC-PK1 vesicles-MDR1 | ||||
Felodipine |
3 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Felodipine inhibits the transportation of Daunorubicin by ABCB1 (IC50 = 26.3 microM) | [3] | |||
Affected Drug/Substrate |
Daunorubicin | Modulation Type | Inhibition | ||
Cell System |
NIH-3T3-G185-MDR1 | ||||
DT Modulation 2 |
Felodipine inhibits the transportation of LDS-751 by ABCB1 (IC50 = 32.3 microM) | [3] | |||
Affected Drug/Substrate |
LDS-751 | Modulation Type | Inhibition | ||
Cell System |
NIH-3T3-G185-MDR1 | ||||
DT Modulation 3 |
Felodipine inhibits the transportation of Rhodamine 123 by ABCB1 (IC50 > 60 microM) | [3] | |||
Affected Drug/Substrate |
Rhodamine 123 | Modulation Type | Inhibition | ||
Cell System |
NIH-3T3-G185-MDR1 | ||||
Fluphenazine |
3 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Fluphenazine inhibits the transportation of Daunorubicin by ABCB1 (IC50 = 6.5 microM) | [3] | |||
Affected Drug/Substrate |
Daunorubicin | Modulation Type | Inhibition | ||
Cell System |
NIH-3T3-G185-MDR1 | ||||
DT Modulation 2 |
Fluphenazine inhibits the transportation of LDS-751 by ABCB1 (IC50 = 5.7 microM) | [3] | |||
Affected Drug/Substrate |
LDS-751 | Modulation Type | Inhibition | ||
Cell System |
NIH-3T3-G185-MDR1 | ||||
DT Modulation 3 |
Fluphenazine inhibits the transportation of Rhodamine 123 by ABCB1 (IC50 = 10.4 microM) | [3] | |||
Affected Drug/Substrate |
Rhodamine 123 | Modulation Type | Inhibition | ||
Cell System |
NIH-3T3-G185-MDR1 | ||||
Dipyridamole |
3 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Dipyridamole inhibits the transportation of Digoxin by ABCB1 (IC50 = 40 microM) | [49] | |||
Affected Drug/Substrate |
Digoxin | Modulation Type | Inhibition | ||
Cell System |
LLC-PK1 vesicles-MDR1 | ||||
DT Modulation 2 |
Dipyridamole inhibits the transportation of Rhodamine 123 by ABCB1 | [21] | |||
Affected Drug/Substrate |
Rhodamine 123 | Modulation Type | Inhibition | ||
Cell System |
Mouse T-lymphoma L5178-MDR1 | ||||
DT Modulation 3 |
Dipyridamole inhibits the activity of ABCB1 | [87] | |||
Quercetin |
3 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Quercetin inhibits the transportation of Ritonavir by ABCB1 (IC50 = 26.4 microM) | [81] | |||
Affected Drug/Substrate |
Ritonavir | Modulation Type | Inhibition | ||
Cell System |
Madin darby canine kidney strain cell line (MDCK)-MDR1 | ||||
DT Modulation 2 |
Quercetin inhibits the transportation of Rhodamine 123 by ABCB1 | [82] | |||
Affected Drug/Substrate |
Rhodamine 123 | Modulation Type | Inhibition | ||
Cell System |
Model organism in vivo (rat) | ||||
DT Modulation 3 |
Quercetin induces the transportation of Ritonavir by ABCB1 | [81] | |||
Affected Drug/Substrate |
Ritonavir | Modulation Type | Inducer | ||
Cell System |
Human enterocyte-like 2 cell (Caco-2)-MDR1 | ||||
Dihydroergocristine |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Dihydroergocristine inhibits the transportation of Calcein AM by ABCB1 (Ki = 511 microM) | [4] | |||
Affected Drug/Substrate |
Calcein AM | Modulation Type | Inhibition | ||
Cell System |
LLC-PK1 vesicles-MDR1 | ||||
DT Modulation 2 |
Dihydroergocristine inhibits the transportation of Vinblastine by ABCB1 (Ki = 16 microM) | [4] | |||
Affected Drug/Substrate |
Vinblastine | Modulation Type | Inhibition | ||
Cell System |
LLC-PK1 vesicles-MDR1 | ||||
Dihydroergotamine |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Dihydroergotamine inhibits the transportation of Calcein AM by ABCB1 (Ki > 1000 microM) | [4] | |||
Affected Drug/Substrate |
Calcein AM | Modulation Type | Inhibition | ||
Cell System |
LLC-PK1 vesicles-MDR1 | ||||
DT Modulation 2 |
Dihydroergotamine inhibits the transportation of Vinblastine by ABCB1 (Ki = 119.94 microM) | [4] | |||
Affected Drug/Substrate |
Vinblastine | Modulation Type | Inhibition | ||
Cell System |
LLC-PK1 vesicles-MDR1 | ||||
Ergonovine |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Ergonovine inhibits the transportation of Calcein AM by ABCB1 (Ki = 115.5 microM) | [4] | |||
Affected Drug/Substrate |
Calcein AM | Modulation Type | Inhibition | ||
Cell System |
LLC-PK1 vesicles-MDR1 | ||||
DT Modulation 2 |
Ergonovine inhibits the transportation of Vinblastine by ABCB1 (Ki > 100 microM) | [4] | |||
Affected Drug/Substrate |
Vinblastine | Modulation Type | Inhibition | ||
Cell System |
LLC-PK1 vesicles-MDR1 | ||||
Ergotamine |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Ergotamine inhibits the transportation of Calcein AM by ABCB1 (Ki = 98.9 microM) | [4] | |||
Affected Drug/Substrate |
Calcein AM | Modulation Type | Inhibition | ||
Cell System |
LLC-PK1 vesicles-MDR1 | ||||
DT Modulation 2 |
Ergotamine inhibits the transportation of Vinblastine by ABCB1 (Ki = 14.25 microM) | [4] | |||
Affected Drug/Substrate |
Vinblastine | Modulation Type | Inhibition | ||
Cell System |
LLC-PK1 vesicles-MDR1 | ||||
Fluconazole |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Fluconazole inhibits the transportation of Calcein AM by ABCB1 (Ki > 1000 microM) | [4] | |||
Affected Drug/Substrate |
Calcein AM | Modulation Type | Inhibition | ||
Cell System |
LLC-PK1 vesicles-MDR1 | ||||
DT Modulation 2 |
Fluconazole inhibits the transportation of Vinblastine by ABCB1 (Ki > 400 microM) | [4] | |||
Affected Drug/Substrate |
Vinblastine | Modulation Type | Inhibition | ||
Cell System |
LLC-PK1 vesicles-MDR1 | ||||
Hydrocortisone |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Hydrocortisone inhibits the transportation of Calcein AM by ABCB1 (IC50 = 50 microM) | [5] | |||
Affected Drug/Substrate |
Calcein AM | Modulation Type | Inhibition | ||
Cell System |
LLC-PK1 vesicles-MDR1 | ||||
DT Modulation 2 |
Hydrocortisone inhibits the transportation of Rhodamine 123 by ABCB1 | [5] | |||
Affected Drug/Substrate |
Rhodamine 123 | Modulation Type | Inhibition | ||
Cell System |
Human enterocyte-like 2 cell (Caco-2)-MDR1 | ||||
Morphine |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Morphine inhibits the transportation of Calcein AM by ABCB1 (IC50 = 50 microM) | [5] | |||
Affected Drug/Substrate |
Calcein AM | Modulation Type | Inhibition | ||
Cell System |
LLC-PK1 vesicles-MDR1 | ||||
DT Modulation 2 |
Morphine inhibits the transportation of Rhodamine 123 by ABCB1 | [5] | |||
Affected Drug/Substrate |
Rhodamine 123 | Modulation Type | Inhibition | ||
Cell System |
Human enterocyte-like 2 cell (Caco-2)-MDR1 | ||||
Pimozide |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Pimozide inhibits the transportation of Calcein AM by ABCB1 (IC50 = 2.9 microM) | [5] | |||
Affected Drug/Substrate |
Calcein AM | Modulation Type | Inhibition | ||
Cell System |
LLC-PK1 vesicles-MDR1 | ||||
DT Modulation 2 |
Pimozide inhibits the transportation of Rhodamine 123 by ABCB1 | [5] | |||
Affected Drug/Substrate |
Rhodamine 123 | Modulation Type | Inhibition | ||
Cell System |
Human enterocyte-like 2 cell (Caco-2)-MDR1 | ||||
Amlodipine |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Amlodipine inhibits the transportation of Daunorubicin by ABCB1 (IC50 = 22 microM) | [88] | |||
Affected Drug/Substrate |
Daunorubicin | Modulation Type | Inhibition | ||
Cell System |
LLC-PK1 vesicles-MDR1 | ||||
DT Modulation 2 |
Amlodipine inhibits the transportation of Rhodamine 123 by ABCB1 | [21] | |||
Affected Drug/Substrate |
Rhodamine 123 | Modulation Type | Inhibition | ||
Cell System |
Mouse T-lymphoma L5178-MDR1 | ||||
Azelastine |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Azelastine inhibits the transportation of Daunorubicin by ABCB1 (IC50 = 16 microM) | [79] | |||
Affected Drug/Substrate |
Daunorubicin | Modulation Type | Inhibition | ||
Cell System |
LLC-PK1 vesicles-MDR1 | ||||
DT Modulation 2 |
Azelastine inhibits the transportation of Digoxin by ABCB1 (IC50 = 30 microM) | [79] | |||
Affected Drug/Substrate |
Digoxin | Modulation Type | Inhibition | ||
Cell System |
LLC-PK1 vesicles-MDR1 | ||||
Nitrendipine |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Nitrendipine inhibits the transportation of Digoxin by ABCB1 (IC50 = 68.2 microM) | [80] | |||
Affected Drug/Substrate |
Digoxin | Modulation Type | Inhibition | ||
Cell System |
LLC-PK1 vesicles-MDR1 | ||||
DT Modulation 2 |
Nitrendipine inhibits the transportation of Calcein AM by ABCB1 | [93] | |||
Affected Drug/Substrate |
Calcein AM | Modulation Type | Inhibition | ||
Cell System |
Madin Darby canine kidney strain II (MDCKII) cells-MDR1 | ||||
Itraconazole |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Itraconazole inhibits the transportation of Digoxin by ABCB1 (IC50 = 0.95 microM) | [50] | |||
Affected Drug/Substrate |
Digoxin | Modulation Type | Inhibition | ||
Cell System |
Madin Darby canine kidney strain II (MDCKII) cells-MDR1 | ||||
DT Modulation 2 |
Itraconazole inhibits the transportation of Digoxin by ABCB1 (IC50 = 2 microM) | [73] | |||
Affected Drug/Substrate |
Digoxin | Modulation Type | Inhibition | ||
Cell System |
Human enterocyte-like 2 cell (Caco-2)-MDR1 | ||||
Nefazodone |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Nefazodone inhibits the transportation of Rhodamine 123 by ABCB1 (IC50 = 4.7 microM) | [90] | |||
Affected Drug/Substrate |
Rhodamine 123 | Modulation Type | Inhibition | ||
Cell System |
Human enterocyte-like 2 cell (Caco-2)-MDR1 | ||||
Paclitaxel |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Paclitaxel inhibits the transportation of Rhodamine 123 by ABCB1 (IC50 = 54 microM) | [11] | |||
Affected Drug/Substrate |
Rhodamine 123 | Modulation Type | Inhibition | ||
Cell System |
NIH-3T3-G185-MDR1 | ||||
Tamoxifen |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Tamoxifen inhibits the transportation of Rhodamine 123 by ABCB1 (IC50 = 7.1 microM) | [11] | |||
Affected Drug/Substrate |
Rhodamine 123 | Modulation Type | Inhibition | ||
Cell System |
NIH-3T3-G185-MDR1 | ||||
DT Modulation 2 |
Tamoxifen induces the activity of ABCB1 | [111] | |||
Rifampicin |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Rifampicin inhibits the transportation of Azidopine by ABCB1 | [91] | |||
Affected Drug/Substrate |
Azidopine | Modulation Type | Inhibition | ||
Cell System |
Myelogenous leukemia cell line (K562)-MDR1 | ||||
DT Modulation 2 |
Rifampicin induces the activity of ABCB1 | [66] | |||
Cell System |
Human colon carcinoma cell lines (LS174T)-MDR1 | ||||
Haloperidol |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Haloperidol inhibits the transportation of Calcein AM by ABCB1 | [92] | |||
Affected Drug/Substrate |
Calcein AM | Modulation Type | Inhibition | ||
Cell System |
Madin Darby canine kidney strain II (MDCKII) cells-MDR1 | ||||
DT Modulation 2 |
Haloperidol inhibits the transportation of Calcein AM by ABCB1 | [55] | |||
Affected Drug/Substrate |
Calcein AM | Modulation Type | Inhibition | ||
Cell System |
NIH 3T3 cells-MDR1 | ||||
Amprenavir |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Amprenavir inhibits the transportation of Calcein AM by ABCB1 | [94] | |||
Affected Drug/Substrate |
Calcein AM | Modulation Type | Inhibition | ||
Cell System |
Madin Darby canine kidney strain II (MDCKII) cells-MDR1 | ||||
DT Modulation 2 |
Amprenavir induces the activity of ABCB1 | [104] | |||
Indinavir |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Indinavir inhibits the transportation of Calcein AM by ABCB1 | [94] | |||
Affected Drug/Substrate |
Calcein AM | Modulation Type | Inhibition | ||
Cell System |
Madin Darby canine kidney strain II (MDCKII) cells-MDR1 | ||||
Pyronaridine |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Pyronaridine inhibits the transportation of doxorubicin by ABCB1 | [95] | |||
Affected Drug/Substrate |
doxorubicin | Modulation Type | Inhibition | ||
Cell System |
Human breast adenocarcinoma cell line (MCF-7)/ADR | ||||
DT Modulation 2 |
Pyronaridine inhibits the transportation of Rhodamine 123 by ABCB1 | [95] | |||
Affected Drug/Substrate |
Rhodamine 123 | Modulation Type | Inhibition | ||
Carbamazepine |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Carbamazepine induces the transportation of Fexofenadine by ABCB1 | [96] | |||
Affected Drug/Substrate |
Fexofenadine | Modulation Type | Inducer | ||
Cell System |
Twelve healthy Japanese volunteers | ||||
DT Modulation 2 |
Carbamazepine induces the activity of ABCB1 | [114] | |||
Apatinib |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Apatinib inhibits the transportation of Adriamycin by ABCB1 | [38] | |||
Affected Drug/Substrate |
Adriamycin | Modulation Type | Inhibition | ||
DT Modulation 2 |
Apatinib inhibits the transportation of Rhodamine 123 by ABCB1 | [38] | |||
Affected Drug/Substrate |
Rhodamine 123 | Modulation Type | Inhibition | ||
Venlafaxine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Venlafaxine inhibits the transportation of Calcein by ABCB1 | [101] | |||
Affected Drug/Substrate |
Calcein | Modulation Type | Inhibition | ||
Telaprevir |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Telaprevir inhibits the transportation of Calcein by ABCB1 | [102] | |||
Affected Drug/Substrate |
Calcein | Modulation Type | Inhibition | ||
DT Modulation 2 |
Telaprevir inhibits the activity of ABCB1 | [106] | |||
Cobicistat |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Cobicistat inhibits the transportation of Dabigatran by ABCB1 | [103] | |||
Affected Drug/Substrate |
Dabigatran | Modulation Type | Inhibition | ||
DT Modulation 2 |
Cobicistat inhibits the activity of ABCB1 | [116] | |||
Nelfinavir |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Nelfinavir induces the activity of ABCB1 | [104] | |||
Biricodar |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Biricodar inhibits the activity of ABCB1 | [105] | |||
DT Modulation 2 |
Biricodar modulates the activity of ABCB1 | [107] | |||
Indomethacin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Indomethacin inhibits the activity of ABCB1 | [108] | |||
Atorvastatin |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Atorvastatin inhibits the activity of ABCB1 | [109] | |||
DT Modulation 2 |
Atorvastatin modulates the activity of ABCB1 | [109] | |||
Arsenic Trioxide |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Arsenic trioxide inhibits the activity of ABCB1 | [110] | |||
Doxorubicin |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Doxorubicin induces the activity of ABCB1 | [112] , [113] | |||
DT Modulation 2 |
Doxorubicin inhibits the activity of ABCB1 | [112] , [113] | |||
Cytarabine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Cytarabine induces the activity of ABCB1 | [115] | |||
Simvastatin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Simvastatin inhibits the transportation of Calcein AM by ABCB1 (IC50 = 10 +/- 8 microM) | [53] | |||
Affected Drug/Substrate |
Calcein AM | Modulation Type | Inhibition | ||
Cell System |
Madin-Darby Canine Kidney (MDCK) cells-MDR1 | ||||
Desloratadine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Desloratadine inhibits the transportation of Daunorubicin by ABCB1 (IC50 = 43 microM) | [118] | |||
Affected Drug/Substrate |
Daunorubicin | Modulation Type | Inhibition | ||
Cell System |
NIH-3T3-G185-MDR1 | ||||
Omeprazole |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Omeprazole inhibits the transportation of Digoxin by ABCB1 (IC50 = 17.7 microM) | [119] | |||
Affected Drug/Substrate |
Digoxin | Modulation Type | Inhibition | ||
Cell System |
Human enterocyte-like 2 cell (Caco-2)-MDR1 | ||||
Pantoprazole |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Pantoprazole inhibits the transportation of Digoxin by ABCB1 (IC50 = 17.9 microM) | [119] | |||
Affected Drug/Substrate |
Digoxin | Modulation Type | Inhibition | ||
Cell System |
Human enterocyte-like 2 cell (Caco-2)-MDR1 | ||||
Alfentanil |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Alfentanil inhibits the transportation of Digoxin by ABCB1 (IC50 = 112 microM) | [120] | |||
Affected Drug/Substrate |
Digoxin | Modulation Type | Inhibition | ||
Cell System |
Human enterocyte-like 2 cell (Caco-2)-MDR1 | ||||
Fentanyl |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Fentanyl inhibits the transportation of Digoxin by ABCB1 (IC50 = 6.5 microM) | [120] | |||
Affected Drug/Substrate |
Digoxin | Modulation Type | Inhibition | ||
Cell System |
Human enterocyte-like 2 cell (Caco-2)-MDR1 | ||||
Sufentanil |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Sufentanil inhibits the transportation of Digoxin by ABCB1 (IC50 = 4.5 microM) | [120] | |||
Affected Drug/Substrate |
Digoxin | Modulation Type | Inhibition | ||
Cell System |
Human enterocyte-like 2 cell (Caco-2)-MDR1 | ||||
Nisoldipine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Nisoldipine inhibits the transportation of Digoxin by ABCB1 (IC50 = 44.1 microM) | [80] | |||
Affected Drug/Substrate |
Digoxin | Modulation Type | Inhibition | ||
Cell System |
LLC-PK1 vesicles-MDR1 | ||||
Azithromycin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Azithromycin inhibits the transportation of Digoxin by ABCB1 (IC50 = 21.8 microM) | [72] | |||
Affected Drug/Substrate |
Digoxin | Modulation Type | Inhibition | ||
Cell System |
Human enterocyte-like 2 cell (Caco-2)-MDR1 | ||||
Clarithromycin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Clarithromycin inhibits the transportation of Digoxin by ABCB1 (IC50 = 4.1 microM) | [72] | |||
Affected Drug/Substrate |
Digoxin | Modulation Type | Inhibition | ||
Cell System |
Human enterocyte-like 2 cell (Caco-2)-MDR1 | ||||
Telithromycin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Telithromycin inhibits the transportation of Digoxin by ABCB1 (IC50 = 1.8 microM) | [72] | |||
Affected Drug/Substrate |
Digoxin | Modulation Type | Inhibition | ||
Cell System |
Human enterocyte-like 2 cell (Caco-2)-MDR1 | ||||
Atovaquone |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Atovaquone inhibits the transportation of N-methyl quinidine by ABCB1 (IC50 = 6.8 microM) | [121] | |||
Affected Drug/Substrate |
N-methyl quinidine | Modulation Type | Inhibition | ||
Cell System |
Human embryonic kidney 293 cells (HEK293)-MDR1 | ||||
Metoprolol |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Metoprolol inhibits the transportation of Verapamil by ABCB1 (Ki = 200 microM) | [125] | |||
Affected Drug/Substrate |
Verapamil | Modulation Type | Inhibition | ||
Cell System |
Human enterocyte-like 2 cell (Caco-2)-MDR1 | ||||
Erlotinib |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Erlotinib inhibits the transportation of Vincristine by ABCB1 (IC50 = 2 microM) | [31] | |||
Affected Drug/Substrate |
Vincristine | Modulation Type | Inhibition | ||
Cell System |
Myelogenous leukemia cell line (K562)-MDR1 | ||||
Paroxetine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Paroxetine inhibits the transportation of Calcein by ABCB1 (IC50 = 29.8 microM) | [101] | |||
Affected Drug/Substrate |
Calcein | Modulation Type | Inhibition | ||
Sertraline |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Sertraline inhibits the transportation of Calcein by ABCB1 (IC50 = 31.8 microM) | [101] | |||
Affected Drug/Substrate |
Calcein | Modulation Type | Inhibition | ||
Loratadine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Loratadine inhibits the transportation of Daunorubicin by ABCB1 (IC50 = 11.4 microM) | [118] | |||
Affected Drug/Substrate |
Daunorubicin | Modulation Type | Inhibition | ||
KB-2796 |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Lomerizine inhibits the transportation of Calcein by ABCB1 | [130] | |||
Affected Drug/Substrate |
Calcein | Modulation Type | Inhibition | ||
Cell System |
Myelogenous leukemia cell line (K562)-MDR1 | ||||
Chlorprothixene |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Chlorprothixene inhibits the transportation of Calcein AM by ABCB1 | [92] | |||
Affected Drug/Substrate |
Calcein AM | Modulation Type | Inhibition | ||
Cell System |
Madin Darby canine kidney strain II (MDCKII) cells-MDR1 | ||||
Clomipramine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Clomipramine inhibits the transportation of Calcein AM by ABCB1 | [92] | |||
Affected Drug/Substrate |
Calcein AM | Modulation Type | Inhibition | ||
Cell System |
Madin Darby canine kidney strain II (MDCKII) cells-MDR1 | ||||
Maprotiline |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Maprotiline inhibits the transportation of Calcein AM by ABCB1 | [92] | |||
Affected Drug/Substrate |
Calcein AM | Modulation Type | Inhibition | ||
Cell System |
Madin Darby canine kidney strain II (MDCKII) cells-MDR1 | ||||
Mebendazole |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Mebendazole inhibits the transportation of Calcein AM by ABCB1 | [93] | |||
Affected Drug/Substrate |
Calcein AM | Modulation Type | Inhibition | ||
Cell System |
Madin Darby canine kidney strain II (MDCKII) cells-MDR1 | ||||
Benzocaine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Benzocaine inhibits the transportation of Calcein AM by ABCB1 | [55] | |||
Affected Drug/Substrate |
Calcein AM | Modulation Type | Inhibition | ||
Cell System |
NIH 3T3 cells-MDR1 | ||||
Prednisone |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Prednisone inhibits the transportation of Calcein AM by ABCB1 | [55] | |||
Affected Drug/Substrate |
Calcein AM | Modulation Type | Inhibition | ||
Cell System |
NIH 3T3 cells-MDR1 | ||||
Tetracaine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Tetracaine inhibits the transportation of Calcein AM by ABCB1 | [55] | |||
Affected Drug/Substrate |
Calcein AM | Modulation Type | Inhibition | ||
Cell System |
NIH 3T3 cells-MDR1 | ||||
Trimipramine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Trimipramine inhibits the transportation of Calcein AM by ABCB1 | [55] | |||
Affected Drug/Substrate |
Calcein AM | Modulation Type | Inhibition | ||
Cell System |
NIH 3T3 cells-MDR1 | ||||
Lopinavir |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Lopinavir inhibits the transportation of Calcein AM by ABCB1 | [94] | |||
Affected Drug/Substrate |
Calcein AM | Modulation Type | Inhibition | ||
Cell System |
Madin Darby canine kidney strain II (MDCKII) cells-MDR1 | ||||
Glyburide |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Glibenclamide inhibits the transportation of Colchicine by ABCB1 | [15] | |||
Affected Drug/Substrate |
Colchicine | Modulation Type | Inhibition | ||
Cell System |
Human T-cell line (CEM)/Tumour cell line-MDR1 | ||||
Doxazosin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Doxazosin inhibits the transportation of Digoxin by ABCB1 | [131] | |||
Affected Drug/Substrate |
Digoxin | Modulation Type | Inhibition | ||
Cell System |
LLC-PK1 vesicles-MDR1 | ||||
Caffeine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Caffeine inhibits the transportation of Digoxin by ABCB1 | [57] | |||
Affected Drug/Substrate |
Digoxin | Modulation Type | Inhibition | ||
Cell System |
Human enterocyte-like 2 cell (Caco-2)-MDR1 | ||||
Chlorzoxazone |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Chlorzoxazone inhibits the transportation of Digoxin by ABCB1 | [57] | |||
Affected Drug/Substrate |
Digoxin | Modulation Type | Inhibition | ||
Cell System |
Human enterocyte-like 2 cell (Caco-2)-MDR1 | ||||
Dolutegravir |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Dolutegravir inhibits the transportation of Digoxin by ABCB1 | [132] | |||
Affected Drug/Substrate |
Digoxin | Modulation Type | Inhibition | ||
Cell System |
Madin Darby canine kidney strain II (MDCKII) cells-MDR1 | ||||
Capsaicin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Capsaicin inhibits the transportation of Fexofenadine by ABCB1 | [133] | |||
Affected Drug/Substrate |
Fexofenadine | Modulation Type | Inhibition | ||
Cell System |
Model organism in vivo (rat) | ||||
Bepridil |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Bepridil inhibits the transportation of Rhodamine 123 by ABCB1 | [134] | |||
Affected Drug/Substrate |
Rhodamine 123 | Modulation Type | Inhibition | ||
Cell System |
NIH 3T3 cells-MDR1 | ||||
Chlorpropamide |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Chlorpropamide inhibits the transportation of Rhodamine 123 by ABCB1 | [134] | |||
Affected Drug/Substrate |
Rhodamine 123 | Modulation Type | Inhibition | ||
Cell System |
NIH 3T3 cells-MDR1 | ||||
Prochlorperazine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Prochlorperazine inhibits the transportation of Rhodamine 123 by ABCB1 | [134] | |||
Affected Drug/Substrate |
Rhodamine 123 | Modulation Type | Inhibition | ||
Cell System |
NIH 3T3 cells-MDR1 | ||||
Promethazine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Promethazine inhibits the transportation of Rhodamine 123 by ABCB1 | [134] | |||
Affected Drug/Substrate |
Rhodamine 123 | Modulation Type | Inhibition | ||
Cell System |
NIH 3T3 cells-MDR1 | ||||
Protriptyline |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Protriptyline inhibits the transportation of Rhodamine 123 by ABCB1 | [134] | |||
Affected Drug/Substrate |
Rhodamine 123 | Modulation Type | Inhibition | ||
Cell System |
Human enterocyte-like 2 cell (Caco-2)-MDR1 | ||||
Aprindine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Aprindine inhibits the transportation of Rhodamine 123 by ABCB1 | [21] | |||
Affected Drug/Substrate |
Rhodamine 123 | Modulation Type | Inhibition | ||
Cell System |
Mouse T-lymphoma L5178-MDR1 | ||||
Aripiprazole |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Aripiprazole inhibits the transportation of Rhodamine 123 by ABCB1 | [21] | |||
Affected Drug/Substrate |
Rhodamine 123 | Modulation Type | Inhibition | ||
Cell System |
Mouse T-lymphoma L5178-MDR1 | ||||
Loperamide |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Loperamide inhibits the transportation of Rhodamine 123 by ABCB1 | [21] | |||
Affected Drug/Substrate |
Rhodamine 123 | Modulation Type | Inhibition | ||
Cell System |
Mouse T-lymphoma L5178-MDR1 | ||||
Repaglinide |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Repaglinide inhibits the transportation of Rhodamine 123 by ABCB1 | [21] | |||
Affected Drug/Substrate |
Rhodamine 123 | Modulation Type | Inhibition | ||
Cell System |
Mouse T-lymphoma L5178-MDR1 | ||||
Ziprasidone |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Ziprasidone inhibits the transportation of Rhodamine 123 by ABCB1 | [21] | |||
Affected Drug/Substrate |
Rhodamine 123 | Modulation Type | Inhibition | ||
Cell System |
Mouse T-lymphoma L5178-MDR1 | ||||
Reboxetine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Reboxetine inhibits the transportation of Calcein by ABCB1 | [101] | |||
Affected Drug/Substrate |
Calcein | Modulation Type | Inhibition | ||
Fluvoxamine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Fluvoxamine inhibits the transportation of Calcein AM by ABCB1 | [101] | |||
Affected Drug/Substrate |
Calcein AM | Modulation Type | Inhibition | ||
Sesquiterpene |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Sesquiterpene inhibits the transportation of Colchicine by ABCB1 | [149] | |||
Affected Drug/Substrate |
Colchicine | Modulation Type | Inhibition | ||
Simeprevir |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Simeprevir inhibits the transportation of Digoxin by ABCB1 | [150] | |||
Affected Drug/Substrate |
Digoxin | Modulation Type | Inhibition | ||
Carvedilol |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Carvedilol inhibits the transportation of Doxorubicin by ABCB1 | [151] | |||
Affected Drug/Substrate |
Doxorubicin | Modulation Type | Inhibition | ||
Dronedarone |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Dronedarone inhibits the transportation of Edoxaban by ABCB1 | [152] | |||
Affected Drug/Substrate |
Edoxaban | Modulation Type | Inhibition | ||
Crizotinib |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Crizotinib inhibits the transportation of Rhodamine 123 by ABCB1 | [153] | |||
Affected Drug/Substrate |
Rhodamine 123 | Modulation Type | Inhibition | ||
Vandetanib |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Vandetanib inhibits the transportation of Rhodamine 123 by ABCB1 | [154] | |||
Affected Drug/Substrate |
Rhodamine 123 | Modulation Type | Inhibition | ||
Estramustine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Estramustine inhibits the transportation of Vinblastine by ABCB1 | [155] | |||
Affected Drug/Substrate |
Vinblastine | Modulation Type | Inhibition | ||
Caspofungin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Caspofungin inhibits the transportation of Vinblastine by ABCB1 | [156] | |||
Affected Drug/Substrate |
Vinblastine | Modulation Type | Inhibition | ||
Buspirone |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Buspirone inhibits the activity of ABCB1 | [92] | |||
Cell System |
Madin Darby canine kidney strain II (MDCKII) cells-MDR1 | ||||
Clotrimazole |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Clotrimazole induces the activity of ABCB1 | [66] | |||
Cell System |
Human colon carcinoma cell lines (LS174T)-MDR1 | ||||
Dexamethasone |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Dexamethasone induces the activity of ABCB1 | [66] | |||
Cell System |
Human colon carcinoma cell lines (LS174T)-MDR1 | ||||
Digoxin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Digoxin induces the activity of ABCB1 | [161] , [162] | |||
Cell System |
Human enterocyte-like 2 cell (Caco-2)-MDR1 | ||||
Liothyronine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Liothyronine induces the activity of ABCB1 | [163] | |||
Cell System |
Human enterocyte-like 2 cell (Caco-2)-MDR1 | ||||
Calcitriol |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Calcitriol inhibits the activity of ABCB1 | [164] | |||
Cell System |
Human embryonic kidney 293 cells (HEK293)-MDR1 | ||||
Bexarotene |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Bexarotene induces the activity of ABCB1 | [165] | |||
Cell System |
Human BBB model derived from hematopoietic stem cells | ||||
Decitabine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Decitabine restores drug sensitivity by depressing ABCB1 activity through MAPK signaling pathway | [172] | |||
Cell System |
K562/ADR cells and MCF-7/ADR cells | ||||
Dihydromyricetin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Dihydromyricetin inhibits the transporation of adriamycin by ABCB1 through ERK/Akt signaling pathways (IC50 = 0.172 microM) | [173] | |||
Affected Drug/Substrate |
Adriamycin | Modulation Type | Inhibition | ||
Cell System |
Human myelogenous leukemia cell line (K562) | ||||
Imatinib Mesylate |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Imatinib Mesylate inhibits the expression of ABCB1 | [174] | |||
Regulation Mechanism |
via the inhibition of Nuclear receptor subfamily 1 group I member 2 (NR1I2) | Transcription Factor Info | |||
Cell System |
Human hepatoblastoma cells (HepG2) | ||||
Doxycycline |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Doxycycline inhibits the expression of ABCB1 | [175] | |||
Regulation Mechanism |
via enhancement of Interferon regulatory factor 1 (IRF1) | Transcription Factor Info | |||
Cell System |
Human gastric adenocarcinoma cells (MKN45) | ||||
Spironolactone |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Spironolactone increases the expression of ABCB1 | [178] | |||
Regulation Mechanism |
via enhancement of Nuclear receptor subfamily 1 group I member 2 (NR1I2) | Transcription Factor Info | |||
Cell System |
Human hepatoblastoma cells (HepG2) | ||||
Estrone |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Estrone increases the expression of ABCB1 | [177] | |||
Regulation Mechanism |
via enhancement of Estrogen receptor (ESR1) | Transcription Factor Info | |||
Cell System |
Human colon adenocarcinoma cells (LS180) | ||||
Flutamide |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Flutamide increases the expression of ABCB1 | [180] | |||
Regulation Mechanism |
via enhancement of Nuclear receptor subfamily 1 group I member 2 (NR1I2) | Transcription Factor Info | |||
Cell System |
Human colon adenocarcinoma cells (LS180) | ||||
Cyclophosphamide |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Cyclophosphamide increases the expression of ABCB1 | [180] | |||
Regulation Mechanism |
via enhancement of Nuclear receptor subfamily 1 group I member 2 (NR1I2) | Transcription Factor Info | |||
Cell System |
Human colon adenocarcinoma cells (LS180) | ||||
Hydrogen Peroxide |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Hydrogen Peroxide increases the expression of ABCB1 | [181] | |||
Regulation Mechanism |
via enhancement of Nuclear factor erythroid 2-related factor 2 (NFE2L2) | Transcription Factor Info | |||
Cell System |
Human colon adenocarcinoma cells (Caco-2) | ||||
Methotrexate |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Methotrexate increases the expression of ABCB1 | [182] | |||
Regulation Mechanism |
via enhancement of Transcription factor SOX-2 (SOX2) | Transcription Factor Info | |||
Cell System |
Human osteosarcoma cells (U-2OS) | ||||
Rifampin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Rifampin increases the expression of ABCB1 | [183] | |||
Regulation Mechanism |
via enhancement of Nuclear receptor subfamily 1 group I member 2 (NR1I2) | Transcription Factor Info | |||
Cell System |
Human colon adenocarcinoma cells (LS180) | ||||
Midostaurin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Midostaurin inhibits the activity of ABCB1 | [184] | |||
Carmustine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Carmustine increases the expression of ABCB1 | [186] | |||
Chlorambucil |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Chlorambucil increases the expression of ABCB1 | [186] | |||
Levonorgestrel |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Levonorgestrel increases the expression of ABCB1 | [177] | |||
Thalidomide |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Thalidomide inhibits the expression of ABCB1 | [190] | |||
Cepharanthine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Cepharanthine inhibits the activity of ABCB1 | [191] | |||
Disulfiram |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Disulfiram inhibits the activity of ABCB1 | [192] | |||
Ursodeoxycholic Acid |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Ursodeoxycholic Acid increases the expression of ABCB1 | [193] | |||
Chlorpromazine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Chlorpromazine inhibits the activity of ABCB1 | [194] | |||
Clozapine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Clozapine inhibits the activity of ABCB1 | [194] | |||
Olanzapine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Olanzapine inhibits the activity of ABCB1 | [194] | |||
Quetiapine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Quetiapine inhibits the activity of ABCB1 | [194] | |||
Diethylstilbestrol |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Diethylstilbestrol inhibits the expression of ABCB1 | [195] | |||
Raloxifene Hydrochloride |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Raloxifene Hydrochloride inhibits the expression of ABCB1 | [196] | |||
Clopidogrel |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Clopidogrel inhibits the expression of ABCB1 | [197] | |||
Venlafaxine Hydrochloride |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Venlafaxine Hydrochloride increases the expression of ABCB1 | [198] | |||
Mitomycin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Mitomycin increases the expression of ABCB1 | [199] | |||
Gabapentin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Gabapentin inhibits the activity of ABCB1 | [200] | |||
Lamotrigine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Lamotrigine inhibits the activity of ABCB1 | [200] | |||
Levetiracetam |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Levetiracetam inhibits the activity of ABCB1 | [200] | |||
Methylprednisolone |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Methylprednisolone increases the expression of ABCB1 | [201] | |||
Ciclesonide |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Ciclesonide increases the expression of ABCB1 | [202] | |||
Lindane |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Lindane increases the expression of ABCB1 | [124] | |||
Fulvestrant |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Fulvestrant increases the expression of ABCB1 | [203] | |||
Estradiol |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Estradiol inhibits the expression of ABCB1 | [204] | |||
Ivermectin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Ivermectin inhibits the activity of ABCB1 | [205] | |||
Abemaciclib |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Abemaciclib inhibits the activity of ABCB1 | [206] | |||
Deoxycholic acid |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Deoxycholic acid increases the expression of ABCB1 | [207] | |||
Bosentan |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Bosentan inhibits the expression of ABCB1 | [208] | |||
Macitentan |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Macitentan inhibits the expression of ABCB1 | [208] | |||
Urethane |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Urethane increases the expression of ABCB1 | [209] | |||
Methoxsalen |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Methoxsalen inhibits the activity of ABCB1 | [210] | |||
Pioglitazone |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Pioglitazone increases the expression of ABCB1 | [211] | |||
Tolbutamide |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Tolbutamide inhibits the activity of ABCB1 | [212] | |||
Titanium dioxide |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Titanium dioxide increases the expression of ABCB1 | [213] | |||
Gemcitabine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Gemcitabine inhibits the expression of ABCB1 | [214] | |||
Mitotane |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Mitotane inhibits the activity of ABCB1 | [215] | |||
Ethinyl Estradiol |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Ethinyl Estradiol increases the expression of ABCB1 | [203] | |||
Zidovudine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Zidovudine increases the expression of ABCB1 | [216] | |||
Romidepsin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Romidepsin increases the expression of ABCB1 | [217] | |||
Risperidone |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Risperidone inhibits the activity of ABCB1 | [218] | |||
Chloroquine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Chloroquine inhibits the expression of ABCB1 | [219] | |||
Dacomitinib |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Dacomitinib inhibits the activity of ABCB1 | [220] | |||
Aldosterone |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Aldosterone induces the activity of ABCB1 | [56] , [26] | |||
Midazolam |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Midazolam induces the activity of ABCB1 | [75] | |||
Phenobarbital |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Phenobarbital induces the activity of ABCB1 | [75] | |||
Sirolimus |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Sirolimus induces the activity of ABCB1 | [75] | |||
Tacrolimus |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Tacrolimus induces the activity of ABCB1 | [75] | |||
Saquinavir |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Saquinavir induces the activity of ABCB1 | [104] , [221] | |||
Trazodone |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Trazodone induces the activity of ABCB1 | [90] | |||
Phenytoin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Phenytoin induces the activity of ABCB1 | [222] | |||
Brilinta |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Brilinta inhibits the activity of ABCB1 | [223] | |||
Canagliflozin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Canagliflozin inhibits the activity of ABCB1 | [223] | |||
Fidaxomicin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Fidaxomicin inhibits the activity of ABCB1 | [223] | |||
Fluoxetine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Fluoxetine inhibits the activity of ABCB1 | [223] | |||
Mirabegron |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Mirabegron inhibits the activity of ABCB1 | [223] | |||
Rifaximin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Rifaximin inhibits the activity of ABCB1 | [223] | |||
Suvorexant |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Suvorexant inhibits the activity of ABCB1 | [223] | |||
Tolvaptan |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Tolvaptan inhibits the activity of ABCB1 | [223] | |||
Vemurafenib |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Vemurafenib inhibits the activity of ABCB1 | [223] | |||
Fosphenytoin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Fosphenytoin induces the activity of ABCB1 | [224] | |||
Donepezil |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Donepezil inhibits the activity of ABCB1 | [225] | |||
Docetaxel |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Docetaxel induces the activity of ABCB1 | [226] | |||
Tretinoin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Tretinoin induces the activity of ABCB1 | [227] , [228] | |||
Cisplatin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Cisplatin induces the activity of ABCB1 | [229] , [230] | |||
Chenodeoxycholic acid |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Chenodeoxycholic acid induces the activity of ABCB1 | [193] | |||
Vincristine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Vincristine induces the activity of ABCB1 | [231] , [232] | |||
Dinoprostone |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Dinoprostone induces the activity of ABCB1 | [233] | |||
Celecoxib |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Celecoxib inhibits the activity of ABCB1 | [233] , [234] | |||
Metformin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Metformin inhibits the activity of ABCB1 | [235] | |||
Fluorouracil |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Fluorouracil induces the activity of ABCB1 | [236] | |||
Ouabain |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Ouabain induces the activity of ABCB1 | [237] , [238] | |||
Epirubicin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Epirubicin induces the activity of ABCB1 | [239] , [240] | |||
Probenecid |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Probenecid inhibits the activity of ABCB1 | [241] , [242] | |||
Mitoxantrone |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Mitoxantrone induces the activity of ABCB1 | [243] | |||
Daunorubicin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Daunorubicin induces the activity of ABCB1 | [244] | |||
Budesonide |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Budesonide induces the activity of ABCB1 | [245] | |||
Oxycodone |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Oxycodone induces the activity of ABCB1 | [246] | |||
Valproic Acid |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Valproic Acid induces the activity of ABCB1 | [247] | |||
Diltiazem |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Diltiazem inhibits the activity of ABCB1 | [248] | |||
Diclofenac |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Diclofenac induces the activity of ABCB1 | [249] | |||
Fenbufen |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Fenbufen induces the activity of ABCB1 | [249] | |||
Acetylcysteine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Acetylcysteine induces the activity of ABCB1 | [250] | |||
Floxacillin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Flucloxacillin induces the activity of ABCB1 | [251] | |||
Acetaminophen |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Acetaminophen induces the activity of ABCB1 | [252] | |||
Hydroxyurea |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Hydroxyurea induces the activity of ABCB1 | [253] | |||
Dimethyl Sulfoxide |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Dimethyl sulfoxide induces the activity of ABCB1 | [254] | |||
Vincamine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Vincamine inhibits the activity of ABCB1 | [255] | |||
Rescinnamine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Rescinnamine induces the activity of ABCB1 | [256] | |||
Yohimbine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Yohimbine induces the activity of ABCB1 | [256] | |||
Dactinomycin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Dactinomycin induces the activity of ABCB1 | [257] | |||
Insulin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Insulin inhibits the activity of ABCB1 | [258] | |||
Artemisinin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Artemisinin induces the activity of ABCB1 | [259] | |||
Vismodegib |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Vismodegib inhibits the activity of ABCB1 | [260] | |||
Conivaptan |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Conivaptan inhibits the activity of ABCB1 | [116] | |||
Daclatasvir |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Daclatasvir inhibits the activity of ABCB1 | [116] | |||
Eliglustat |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Eliglustat inhibits the activity of ABCB1 | [116] | |||
Everolimus |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Everolimus inhibits the activity of ABCB1 | [116] | |||
Flibanserin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Flibanserin inhibits the activity of ABCB1 | [116] | |||
Fosamprenavir |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Fosamprenavir induces the activity of ABCB1 | [116] | |||
Ivacaftor |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Ivacaftor inhibits the activity of ABCB1 | [116] | |||
Lapatinib |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Lapatinib inhibits the activity of ABCB1 | [116] | |||
Ledipasvir |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Ledipasvir inhibits the activity of ABCB1 | [116] | |||
Pibrentasvir |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Pibrentasvir inhibits the activity of ABCB1 | [116] | |||
Posaconazole |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Posaconazole inhibits the activity of ABCB1 | [116] | |||
Rolapitant |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Rolapitant inhibits the activity of ABCB1 | [116] | |||
Ticagrelor |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Ticagrelor inhibits the activity of ABCB1 | [116] | |||
Velpatasvir |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Velpatasvir inhibits the activity of ABCB1 | [116] | |||
Captopril |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Captopril inhibits the activity of ABCB1 | [116] | |||
Etravirine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Etravirine inhibits the activity of ABCB1 | [116] | |||
Isradipine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Isradipine inhibits the activity of ABCB1 | [116] | |||
Lomitapide |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Lomitapide inhibits the activity of ABCB1 | [116] | |||
Naproxen |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Naproxen inhibits the activity of ABCB1 | [116] | |||
Nilotinib |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Nilotinib inhibits the activity of ABCB1 | [116] | |||
Propafenone |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Propafenone inhibits the activity of ABCB1 | [116] | |||
Ranolazine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Ranolazine inhibits the activity of ABCB1 | [116] | |||
Telmisartan |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Telmisartan inhibits the activity of ABCB1 | [116] | |||
Glecaprevir |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Glecaprevir inhibits the activity of ABCB1 | [261] | |||
Vancomycin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Vancomycin inhibits the activity of ABCB1 | [262] | |||
Eetuximab |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Eetuximab induces the activity of ABCB1 | [263] | |||
Oxytetracycline |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Oxytetracycline induces the activity of ABCB1 | [264] | |||
Micafungin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Micafungin inhibits the activity of ABCB1 | [265] | |||
Betamethasone |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Betamethasone induces the activity of ABCB1 | [266] | |||
Bortezomib |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Bortezomib inhibits the expression of ABCB1 | [267] | |||
Regulation Mechanism |
via the inhibition of Transcription factor p65 (RELA) | Transcription Factor Info | |||
Affected Drug/Substrate |
Daunorubicin | Modulation Type | Inhibition | ||
Cell System |
Human chronic myeloid leukemia cells (K-562) | ||||
Pentoxifylline |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Pentoxifylline inhibits the expression of ABCB1 | [268] | |||
Regulation Mechanism |
via the inhibition of Transcription factor p65 (RELA) | Transcription Factor Info | |||
Affected Drug/Substrate |
Doxorubicin | Modulation Type | Inhibition | ||
Cell System |
Human breast cancer cells (MDA-MB-231); human breast cancer cells (MDA-MB-231) | ||||
Ifosfamide |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Ifosfamide increases the expression of ABCB1 | [180] | |||
Regulation Mechanism |
via enhancement of Nuclear receptor subfamily 1 group I member 2 (NR1I2) | Transcription Factor Info | |||
Affected Drug/Substrate |
Doxorubicin | Modulation Type | Inducer | ||
Cell System |
Human colon adenocarcinoma cells (LS180) | ||||
Topotecan |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Topotecan inhibits the expression of ABCB1 | [269] | |||
Regulation Mechanism |
via the inhibition of Hypoxia-inducible factor 1-alpha (HIF1A) | Transcription Factor Info | |||
Affected Drug/Substrate |
Paclitaxel | Modulation Type | Inhibition | ||
Cell System |
Human ovarian serous adenocarcinoma cells (Caov-3) | ||||
Rosiglitazone |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Rosiglitazone inhibits the expression of ABCB1 | [270] | |||
Regulation Mechanism |
via enhancement of Peroxisome proliferator-activated receptor gamma (PPARG) | Transcription Factor Info | |||
Affected Drug/Substrate |
Paclitaxel | Modulation Type | Inhibition | ||
Cell System |
Human ovarian endometrioid adenocarcinoma cells (A2780) | ||||
Drug Marketed but not Approved by US FDA |
|||||
Formononetin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Formononetin increases the expression of ABCB1 | [176] | |||
Regulation Mechanism |
via enhancement of Nuclear factor erythroid 2-related factor 2 (NFE2L2) | Transcription Factor Info | |||
Cell System |
C57BL/6 mice | ||||
Estriol |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Estriol increases the expression of ABCB1 | [177] | |||
Regulation Mechanism |
via enhancement of Estrogen receptor (ESR1) | Transcription Factor Info | |||
Cell System |
Human colon adenocarcinoma cells (LS180) | ||||
Ginkgolide A |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Ginkgolide A increases the expression of ABCB1 | [179] | |||
Regulation Mechanism |
via enhancement of Nuclear receptor subfamily 1 group I member 2 (NR1I2) | Transcription Factor Info | |||
Cell System |
Human hepatoblastoma cells (HepG2) | ||||
Demecolcine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Demecolcine increases the activity of ABCB1 | [185] | |||
Tocotrienol beta |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Tocotrienol beta increases the expression of ABCB1 | [187] | |||
Tocotrienol delta |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Tocotrienol delta increases the expression of ABCB1 | [187] | |||
Rotenone |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Rotenone affects the activity of ABCB1 | [189] | |||
Drug in Phase 2/3 Trial |
|||||
Silibinin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Silibinin inhibits the transportation of Ritonavir by ABCB1 | [81] | |||
Affected Drug/Substrate |
Ritonavir | Modulation Type | Inhibition | ||
Cell System |
Madin darby canine kidney strain cell line (MDCK)-MDR1 | ||||
Butyric Acid |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Butyric Acid increases the expression of ABCB1 | [188] | |||
Drug in Phase 3 Trial |
|||||
Curcumin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Curcumin inhibits the transportation of Rhodamine 123 by ABCB1 | [136] | |||
Affected Drug/Substrate |
Rhodamine 123 | Modulation Type | Inhibition | ||
Cell System |
Multidrug resistance human gastric carcinoma cell line (SGC7901/VCR)-MDR1 | ||||
Istradefylline |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Istradefylline inhibits the transportation of Atorvastatin by ABCB1 | [157] | |||
Affected Drug/Substrate |
Atorvastatin | Modulation Type | Inhibition | ||
Glycyrrhizin (high concentration) |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Glycyrrhizin (high concentration) inhibits the activity of ABCB1 | [166] | |||
Cell System |
Model organism in vivo (rat) | ||||
Oltipraz |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Oltipraz increases the expression of ABCB1 | [286] | |||
Sulforafan |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Sulforafan inhibits the expression of ABCB1 | [272] | |||
Triclosan |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Triclosan increases the expression of ABCB1 | [318] | |||
Afimoxifene |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Afimoxifene increases the expression of ABCB1 | [330] | |||
Asunaprevir |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Asunaprevir inhibits the activity of ABCB1 | [223] | |||
Elobixibat |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Elobixibat inhibits the activity of ABCB1 | [223] | |||
Trabectedin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Trabectedin inhibits the activity of ABCB1 | [336] | |||
Isavuconazole |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Isavuconazole inhibits the activity of ABCB1 | [116] | |||
Epigallocatechin gallate |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Epigallocatechin gallate inhibits the expression of ABCB1 | [337] | |||
Regulation Mechanism |
via enhancement of Transcription factor p65 (RELA) | Transcription Factor Info | |||
Affected Drug/Substrate |
5-fluorouracil | Modulation Type | Inhibition | ||
Cell System |
Human colon carcinoma cells (HCT-116) | ||||
Resveratrol |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Resveratrol inhibits the expression of ABCB1 | [340] | |||
Regulation Mechanism |
via the inhibition of Transcription factor p65 (RELA) | Transcription Factor Info | |||
Affected Drug/Substrate |
Oxaliplatin | Modulation Type | Inhibition | ||
Cell System |
Human colon carcinoma cells (HCT 116) | ||||
Drug in Phase 2 Trial |
|||||
DT Modulation 1 |
Genistein induces the activity of ABCB1 | [100] | |||
Cell System |
Human hepatocellular carcinoma cell line (HepG2)-MDR1 | ||||
Icaritin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Icaritin inhibits the activity of ABCB1 | [58] | |||
Cell System |
Human enterocyte-like 2 cell (Caco-2)-MDR1 | ||||
Ursolic acid |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Ursolic acid increases the expression of ABCB1 | [274] | |||
Regulation Mechanism |
via enhancement of Nuclear receptor subfamily 1 group I member 2 (NR1I2) | Transcription Factor Info | |||
Cell System |
Human colon adenocarcinoma cells (LS180) | ||||
Colforsin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Colforsin increases the expression of ABCB1 | [281] | |||
Bisphenol B |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Bisphenol B increases the expression of ABCB1 | [300] | |||
Camptothecin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Camptothecin inhibits the expression of ABCB1 | [317] | |||
Ethanol |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Ethanol increases the expression of ABCB1 | [329] | |||
Bisphenol A |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Bisphenol A increases the expression of ABCB1 | [333] | |||
Drug in Phase 1 Trial |
|||||
Naringenin |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Naringenin inhibits the transportation of Talinolol by ABCB1 (IC50 = 2409 microM) | [63] | |||
Affected Drug/Substrate |
Talinolol | Modulation Type | Inhibition | ||
Cell System |
Human enterocyte-like 2 cell (Caco-2)-MDR1 | ||||
DT Modulation 2 |
Naringenin inhibits the transportation of Rhodamine 123 by ABCB1 | [82] | |||
Affected Drug/Substrate |
Rhodamine 123 | Modulation Type | Inhibition | ||
Cell System |
Model organism in vivo (rat) | ||||
Butyrate |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Butyrate increases the expression of ABCB1 | [275] | |||
Regulation Mechanism |
via enhancement of Signal transducer and activator of transcription 3 (STAT3) | Transcription Factor Info | |||
Cell System |
Human lung adenocarcinoma cells (A549) | ||||
Sodium arsenite |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Sodium arsenite increases the expression of ABCB1 | [278] | |||
CCRIS-9277 |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
CCRIS-9277 inhibits the activity of ABCB1 | [282] | |||
LY-294002 |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
LY-294002 inhibits the expression of ABCB1 | [304] | |||
HSDB-3466 |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
HSDB-3466 inhibits the activity of ABCB1 | [210] | |||
Luteolin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Luteolin inhibits the expression of ABCB1 | [327] | |||
Trichostatin A |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Trichostatin A increases the expression of ABCB1 | [334] | |||
Tetrandrine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Tetrandrine inhibits the expression of ABCB1 | [341] | |||
Regulation Mechanism |
via the inhibition of Nuclear factor NF-kappa-B p105 subunit (NFKB1) | Transcription Factor Info | |||
Affected Drug/Substrate |
Paclitaxel | Modulation Type | Inhibition | ||
Cell System |
Human osteosarcoma cells (U-2OS) | ||||
SR-12813 |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
SR-12813 increases the expression of ABCB1 | [342] | |||
Regulation Mechanism |
via enhancement of Nuclear receptor subfamily 1 group I member 2 (NR1I2) | Transcription Factor Info | |||
Affected Drug/Substrate |
Paclitaxel | Modulation Type | Inducer | ||
Cell System |
Human breast adenocarcinoma cells (MDA-MB-231) | ||||
NS-398 |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
NS-398 increases the expression of ABCB1 | [343] | |||
Regulation Mechanism |
via enhancement of Transcription factor Jun (JUN) | Transcription Factor Info | |||
Affected Drug/Substrate |
Vincristine | Modulation Type | Inducer | ||
Cell System |
Human colorectal cancer cells (HCT8) | ||||
Drug in Preclinical Test |
|||||
(+)-JQ1 |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
(+)-JQ1 inhibits the expression of ABCB1 | [309] | |||
Epinephrine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Epinephrine induces the activity of ABCB1 | [335] | |||
Dioscin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Dioscin inhibits the expression of ABCB1 | [338] | |||
Regulation Mechanism |
via enhancement of Nuclear factor NF-kappa-B p105 subunit (NFKB1) | Transcription Factor Info | |||
Affected Drug/Substrate |
Adriamycin | Modulation Type | Inhibition | ||
Cell System |
Human invasive breast carcinoma of no special type cells (MCF-7) | ||||
Discontinued Drug |
|||||
Valspodar |
13 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Valspodar inhibits the transportation of Digoxin by ABCB1 (IC50 = 0.11 microM) | [8] | |||
Affected Drug/Substrate |
Digoxin | Modulation Type | Inhibition | ||
Cell System |
Human enterocyte-like 2 cell (Caco-2)-MDR1 | ||||
DT Modulation 2 |
Valspodar inhibits the transportation of Digoxin by ABCB1 (IC50 = 0.0222 microM) | [42] | |||
Affected Drug/Substrate |
Digoxin | Modulation Type | Inhibition | ||
Cell System |
LLC-PK1 vesicles-MDR1 | ||||
DT Modulation 3 |
Valspodar inhibits the transportation of Doxorubicin by ABCB1 (IC50 = 0.291 microM) | [10] | |||
Affected Drug/Substrate |
Doxorubicin | Modulation Type | Inhibition | ||
Cell System |
LLC-PK1 vesicles-MDR1 | ||||
DT Modulation 4 |
Valspodar inhibits the transportation of Vinblastine by ABCB1 (IC50 = 1.06 microM) | [10] | |||
Affected Drug/Substrate |
Vinblastine | Modulation Type | Inhibition | ||
Cell System |
LLC-PK1 vesicles-MDR1 | ||||
DT Modulation 5 |
Valspodar inhibits the transportation of Calcein AM by ABCB1 (Ki = 1.3 microM) | [1] | |||
Affected Drug/Substrate |
Calcein AM | Modulation Type | Inhibition | ||
DT Modulation 6 |
Valspodar inhibits the transportation of Verapamil by ABCB1 (Ki = 0.134 microM) | [43] | |||
Affected Drug/Substrate |
Verapamil | Modulation Type | Inhibition | ||
DT Modulation 7 |
Valspodar inhibits the transportation of Cyclosporin A by ABCB1 | [44] | |||
Affected Drug/Substrate |
Cyclosporine A | Modulation Type | Inhibition | ||
Cell System |
Madin Darby canine kidney strain II (MDCKII) cells-MDR1 | ||||
DT Modulation 8 |
Valspodar inhibits the transportation of Indinavir by ABCB1 | [45] | |||
Affected Drug/Substrate |
Indinavir | Modulation Type | Inhibition | ||
Cell System |
Human enterocyte-like 2 cell (Caco-2)-MDR1 | ||||
DT Modulation 9 |
Valspodar inhibits the transportation of Iodoaryl-azidoprazosin by ABCB1 | [46] | |||
Affected Drug/Substrate |
Iodoaryl-azidoprazosin | Modulation Type | Inhibition | ||
Cell System |
CEM/VLB100 drug-resistant cells-MDR1 | ||||
DT Modulation 10 |
Valspodar inhibits the transportation of mitoxantrone by ABCB1 | [47] | |||
Affected Drug/Substrate |
mitoxantrone | Modulation Type | Inhibition | ||
Cell System |
Human breast adenocarcinoma cell line (MCF-7)-MDR1 | ||||
DT Modulation 11 |
Valspodar inhibits the transportation of Nelfinavir by ABCB1 | [45] | |||
Affected Drug/Substrate |
Nelfinavir | Modulation Type | Inhibition | ||
Cell System |
Human enterocyte-like 2 cell (Caco-2)-MDR1 | ||||
DT Modulation 12 |
Valspodar inhibits the transportation of Saquinavir by ABCB1 | [45] | |||
Affected Drug/Substrate |
Saquinavir | Modulation Type | Inhibition | ||
Cell System |
Human enterocyte-like 2 cell (Caco-2)-MDR1 | ||||
DT Modulation 13 |
Valspodar inhibits the transportation of Calcein AM by ABCB1 | [48] | |||
Affected Drug/Substrate |
Calcein AM | Modulation Type | Inhibition | ||
Elacridar |
8 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Elacridar inhibits the transportation of Colchicine by ABCB1 (IC50 = 0.027 microM) | [6] | |||
Affected Drug/Substrate |
Colchicine | Modulation Type | Inhibition | ||
Cell System |
Madin Darby canine kidney strain II (MDCKII) cells-MDR1 | ||||
DT Modulation 2 |
Elacridar inhibits the transportation of Digoxin by ABCB1 (Ki = 0.44 microM) | [7] | |||
Affected Drug/Substrate |
Digoxin | Modulation Type | Inhibition | ||
Cell System |
Madin-Darby Canine Kidney (MDCK) cells-MDR1 | ||||
DT Modulation 3 |
Elacridar inhibits the transportation of Digoxin by ABCB1 (Ki = 0.39 microM) | [7] | |||
Affected Drug/Substrate |
Digoxin | Modulation Type | Inhibition | ||
Cell System |
Human enterocyte-like 2 cell (Caco-2)-MDR1 | ||||
DT Modulation 4 |
Elacridar inhibits the transportation of Digoxin by ABCB1 (IC50 = 0.18 microM) | [50] | |||
Affected Drug/Substrate |
Digoxin | Modulation Type | Inhibition | ||
Cell System |
Madin Darby canine kidney strain II (MDCKII) cells-MDR1 | ||||
DT Modulation 5 |
Elacridar inhibits the transportation of Digoxin by ABCB1 (IC50 = 0.055 microM) | [6] | |||
Affected Drug/Substrate |
Digoxin | Modulation Type | Inhibition | ||
Cell System |
Madin Darby canine kidney strain II (MDCKII) cells-MDR1 | ||||
DT Modulation 6 |
Elacridar inhibits the transportation of Vinblastine by ABCB1 (IC50 = 0.043 microM) | [6] | |||
Affected Drug/Substrate |
Vinblastine | Modulation Type | Inhibition | ||
Cell System |
Madin Darby canine kidney strain II (MDCKII) cells-MDR1 | ||||
DT Modulation 7 |
Elacridar inhibits the transportation of Quinine by ABCB1 | [51] | |||
Affected Drug/Substrate |
Quinine | Modulation Type | Inhibition | ||
Cell System |
LLC-PK1 porcine kidney epithelial (LLC-GA5-COL150) cells-MDR1 | ||||
DT Modulation 8 |
Elacridar inhibits the transportation of Mitoxantrone by ABCB1 | [52] | |||
Affected Drug/Substrate |
Mitoxantrone | Modulation Type | Inhibition | ||
Tariquidar |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Tariquidar inhibits the transportation of Rhodamine 123 by ABCB1 | [97] | |||
Affected Drug/Substrate |
Rhodamine 123 | Modulation Type | Inhibition | ||
Cell System |
Madin Darby canine kidney strain II (MDCKII) cells-MDR1 | ||||
DT Modulation 2 |
Tariquidar inhibits the activity of ABCB1 | [117] | |||
Brecanavir |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Brecanavir inhibits the transportation of Calcein AM by ABCB1 | [94] | |||
Affected Drug/Substrate |
Calcein AM | Modulation Type | Inhibition | ||
Cell System |
Madin Darby canine kidney strain II (MDCKII) cells-MDR1 | ||||
Miltirone |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Miltirone inhibits the transportation of Doxorubicin by ABCB1 | [135] | |||
Affected Drug/Substrate |
Doxorubicin | Modulation Type | Inhibition | ||
Cell System |
Human hepatoma HepaRG cells-MDR1 | ||||
Epothilone D |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Epothilone D inhibits the transportation of Calcein AM by ABCB1 | [158] | |||
Affected Drug/Substrate |
Calcein AM | Modulation Type | Inhibition | ||
Investigative Drug |
|||||
Hyperforin |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Hyperforin inhibits the transportation of Ritonavir by ABCB1 | [81] | |||
Affected Drug/Substrate |
Ritonavir | Modulation Type | Inhibition | ||
Cell System |
Human enterocyte-like 2 cell (Caco-2)-MDR1 | ||||
DT Modulation 2 |
Hyperforin induces the activity of ABCB1 | [85] | |||
Cell System |
Human gastrointestinal epithelial cell line (LS-180)-MDR1 | ||||
Kaempferol |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Kaempferol inhibits the transportation of Ritonavir by ABCB1 (IC50 = 146.7 microM) | [81] | |||
Affected Drug/Substrate |
Ritonavir | Modulation Type | Inhibition | ||
Cell System |
Madin darby canine kidney strain cell line (MDCK)-MDR1 | ||||
Naringin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Naringin inhibits the transportation of Talinolol by ABCB1 (IC50 = 236 microM) | [63] | |||
Affected Drug/Substrate |
Talinolol | Modulation Type | Inhibition | ||
Cell System |
Human enterocyte-like 2 cell (Caco-2)-MDR1 | ||||
2'-Hydroxychalcone |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
2'-Hydroxychalcone inhibits the transportation of Calcein AM by ABCB1 | [138] | |||
Affected Drug/Substrate |
Calcein AM | Modulation Type | Inhibition | ||
Cell System |
Doxorubicin resistant A2780adr cell lines-MDR1 | ||||
Daidzein |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Daidzein induces the transportation of Rhodamine 123 by ABCB1 | [145] | |||
Affected Drug/Substrate |
Rhodamine 123 | Modulation Type | Inducer | ||
Cell System |
Human colon carcinoma LS-180 cells (LS-180V)-MDR1 | ||||
Corticosterone |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Corticosterone induces the activity of ABCB1 | [66] | |||
Cell System |
Human colon carcinoma cell lines (LS174T)-MDR1 | ||||
Chlorogenic acid |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Chlorogenic acid inhibits the activity of ABCB1 | [166] | |||
Cell System |
Model organism in vivo (rat) | ||||
Manganese |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Manganese increases the activity of ABCB1 | [279] | |||
N-ethylmaleimide |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
N-ethylmaleimide inhibits the activity of ABCB1 | [279] | |||
Methoxyamphetamine beta |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Methoxyamphetamine beta inhibits the activity of ABCB1 | [282] | |||
Chloropyrifos oxon |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Chloropyrifos oxon increases the expression of ABCB1 | [284] | |||
PB28 |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
PB28 inhibits the expression of ABCB1 | [287] | |||
Lithocholic Acid |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Lithocholic Acid increases the expression of ABCB1 | [293] | |||
Phloxine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Phloxine inhibits the activity of ABCB1 | [296] | |||
Glucose |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Glucose inhibits the expression of ABCB1 | [301] | |||
Methylenedioxyamphetamine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Methylenedioxyamphetamine increases the activity of ABCB1 | [303] | |||
3,3',4,5'-tetrahydroxystilbene |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
3,3',4,5'-tetrahydroxystilbene increases the expression of ABCB1 | [321] | |||
27-hydroxycholesterol |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
27-hydroxycholesterol increases the expression of ABCB1 | [326] | |||
Patented Pharmaceutical Agent |
|||||
Geneticin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Geneticin inhibits the expression of ABCB1 | [295] | |||
HSDB-595 |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
HSDB-595 increases the expression of ABCB1 | [302] | |||
K-7174 |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
K-7174 increases the expression of ABCB1 | [306] | |||
Ro-21-5104 |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Ro-21-5104 increases the expression of ABCB1 | [307] | |||
BMS 536924 |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
BMS 536924 inhibits the expression of ABCB1 | [312] | |||
GSK-J4 |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
GSK-J4 increases the expression of ABCB1 | [316] | |||
GW-7647 |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
GW-7647 increases the expression of ABCB1 | [322] | |||
Drug Withdrawn |
|||||
Astemizole |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Astemizole inhibits the transportation of Digoxin by ABCB1 (IC50 = 2.73 microM) | [50] | |||
Affected Drug/Substrate |
Digoxin | Modulation Type | Inhibition | ||
Cell System |
Madin Darby canine kidney strain II (MDCKII) cells-MDR1 | ||||
DT Modulation 2 |
Astemizole inhibits the transportation of Rhodamine 123 by ABCB1 | [21] | |||
Affected Drug/Substrate |
Rhodamine 123 | Modulation Type | Inhibition | ||
Cell System |
Mouse T-lymphoma L5178-MDR1 | ||||
Roxithromycin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Roxithromycin inhibits the transportation of Digoxin by ABCB1 (IC50 = 15.4 microM) | [72] | |||
Affected Drug/Substrate |
Digoxin | Modulation Type | Inhibition | ||
Cell System |
Human enterocyte-like 2 cell (Caco-2)-MDR1 | ||||
Alprenolol |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Alprenolol inhibits the transportation of Rhodamine 123 by ABCB1 | [21] | |||
Affected Drug/Substrate |
Rhodamine 123 | Modulation Type | Inhibition | ||
Cell System |
Mouse T-lymphoma L5178-MDR1 | ||||
Sertindole |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Sertindole inhibits the transportation of Rhodamine 123 by ABCB1 | [21] | |||
Affected Drug/Substrate |
Rhodamine 123 | Modulation Type | Inhibition | ||
Cell System |
Mouse T-lymphoma L5178-MDR1 | ||||
Retigabine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Ezogabine inhibits the transportation of Digoxin by ABCB1 | [159] | |||
Affected Drug/Substrate |
Digoxin | Modulation Type | Inhibition | ||
Flupenthixol |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Flupenthixol inhibits the activity of ABCB1 | [280] | |||
Terfenadine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Terfenadine inhibits the activity of ABCB1 | [280] | |||
Nimesulide |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Nimesulide inhibits the expression of ABCB1 | [299] | |||
Quinidine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Quinidine inhibits the activity of ABCB1 | [116] | |||
Natural Product |
|||||
Piperine |
5 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Piperine inhibits the transportation of Cyclosporine A by ABCB1 (IC50 = 74.1 microM) | [59] | |||
Affected Drug/Substrate |
Cyclosporine A | Modulation Type | Inhibition | ||
Cell System |
Human enterocyte-like 2 cell (Caco-2)-MDR1 | ||||
DT Modulation 2 |
Piperine inhibits the transportation of Digoxin by ABCB1 (IC50 = 15.5 microM) | [59] | |||
Affected Drug/Substrate |
Digoxin | Modulation Type | Inhibition | ||
Cell System |
Human enterocyte-like 2 cell (Caco-2)-MDR1 | ||||
DT Modulation 3 |
Piperine increases the expression of ABCB1 | [64] | |||
Regulation Mechanism |
via enhancement of Nuclear receptor subfamily 1 group I member 2 (NR1I2) | Transcription Factor Info | |||
Affected Drug/Substrate |
Diltiazem | Modulation Type | Inducer | ||
Cell System |
Human colon adenocarcinoma cells (Caco-2) | ||||
DT Modulation 4 |
Piperine inhibits the transportation of Fexofenadine by ABCB1 | [65] | |||
Affected Drug/Substrate |
Fexofenadine | Modulation Type | Inhibition | ||
Cell System |
Model organism in vivo (rat) | ||||
DT Modulation 5 |
Piperine induces the activity of ABCB1 | [68] | |||
Cell System |
Multiple cell lines of human | ||||
SGX301 |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Hypericin inhibits the transportation of Ritonavir by ABCB1 (IC50 = 247 microM) | [81] | |||
Affected Drug/Substrate |
Ritonavir | Modulation Type | Inhibition | ||
Cell System |
Madin darby canine kidney strain cell line (MDCK)-MDR1 | ||||
DT Modulation 2 |
Hypericin induces the activity of ABCB1 | [85] | |||
Cell System |
Human gastrointestinal epithelial cell line (LS-180)-MDR1 | ||||
Garlic extract |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Garlic extract induces the transportation of Rhodamine 123 by ABCB1 | [83] | |||
Affected Drug/Substrate |
Rhodamine 123 | Modulation Type | Inducer | ||
Cell System |
Model organism in vivo (rat) | ||||
DT Modulation 2 |
Garlic extract induces the transportation of Saquinavir by ABCB1 | [84] | |||
Affected Drug/Substrate |
Saquinavir | Modulation Type | Inducer | ||
Cell System |
Healthy people | ||||
St Johns wort extract |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
St Johns wort extract inhibits the transportation of Digoxin by ABCB1 (IC50 = 15.4 microM) | [89] | |||
Affected Drug/Substrate |
Digoxin | Modulation Type | Inhibition | ||
Cell System |
Human enterocyte-like 2 cell (Caco-2)-MDR1 | ||||
DT Modulation 2 |
St Johns wort extract increases the expression of ABCB1 | [98] | |||
Regulation Mechanism |
via enhancement of Nuclear receptor subfamily 1 group I member 2 (NR1I2) | Transcription Factor Info | |||
Cell System |
Sprague-Dawley rats | ||||
Gingerol |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Gingerol inhibits the transportation of Daunorubicin by ABCB1 | [99] | |||
Affected Drug/Substrate |
Daunorubicin | Modulation Type | Inhibition | ||
Cell System |
Multiple drug-resistant human KB carcinoma cell line (KB-C2)-MDR1 | ||||
DT Modulation 2 |
Gingerol inhibits the transportation of Rhodamine 123 by ABCB1 | [99] | |||
Affected Drug/Substrate |
Rhodamine 123 | Modulation Type | Inhibition | ||
Cell System |
Multiple drug-resistant human KB carcinoma cell line (KB-C2)-MDR1 | ||||
Genistein |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Genistein induces the transportation of Sorafenib by increasing ABCB1 expression at translational and transcriptional levels | [100] | |||
Affected Drug/Substrate |
Sorafenib | Modulation Type | Inducer | ||
Cell System |
Human hepatocellular carcinoma cell line (HepG2)-MDR1 | ||||
Ginkgo biloba extract |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Ginkgo biloba extract inhibits the transportation of Digoxin by ABCB1 (IC50 = 23.6 microM) | [89] | |||
Affected Drug/Substrate |
Digoxin | Modulation Type | Inhibition | ||
Cell System |
Human enterocyte-like 2 cell (Caco-2)-MDR1 | ||||
Acetochlor |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Acetochlor inhibits the transportation of Paclitaxel by ABCB1 (IC50 = 25 microM) | [122] | |||
Affected Drug/Substrate |
Paclitaxel | Modulation Type | Inhibition | ||
Cell System |
Myelogenous leukemia cell line (K562)-MDR1 | ||||
Alachlor |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Alachlor inhibits the transportation of Paclitaxel by ABCB1 (IC50 = 25 microM) | [122] | |||
Affected Drug/Substrate |
Paclitaxel | Modulation Type | Inhibition | ||
Cell System |
Myelogenous leukemia cell line (K562)-MDR1 | ||||
Cigarette smoke condensate |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Cigarette smoke condensate inhibits the transportation of Rhodamine 123 by ABCB1 (IC50 = 224.3 microM) | [123] | |||
Affected Drug/Substrate |
Rhodamine 123 | Modulation Type | Inhibition | ||
Cell System |
Human hepatoma HepaRG cells-MDR1 | ||||
Chlordecone |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Chlordecone inhibits the transportation of Rhodamine 123 by ABCB1 (IC50 = 138.8 microM) | [124] | |||
Affected Drug/Substrate |
Rhodamine 123 | Modulation Type | Inhibition | ||
Cell System |
Human breast adenocarcinoma cell line (MCF-7)-MDR1 | ||||
Allicin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Allicin inhibits the transportation of Ritonavir by ABCB1 (IC50 = 119.1 microM) | [81] | |||
Affected Drug/Substrate |
Ritonavir | Modulation Type | Inhibition | ||
Cell System |
Madin darby canine kidney strain cell line (MDCK)-MDR1 | ||||
6,7-dihydroxybergamottin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
6,7-dihydroxybergamottin inhibits the transportation of Talinolol by ABCB1 (IC50 = 34 microM) | [63] | |||
Affected Drug/Substrate |
Talinolol | Modulation Type | Inhibition | ||
Cell System |
Human enterocyte-like 2 cell (Caco-2)-MDR1 | ||||
6,7-epoxybergamottin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
6,7-epoxybergamottin inhibits the transportation of Talinolol by ABCB1 (IC50 = 0.7 microM) | [63] | |||
Affected Drug/Substrate |
Talinolol | Modulation Type | Inhibition | ||
Cell System |
Human enterocyte-like 2 cell (Caco-2)-MDR1 | ||||
Endosulfan |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Endosulfan inhibits the transportation of Verapamil by ABCB1 (IC50 = 1.5 microM) | [126] | |||
Affected Drug/Substrate |
Verapamil | Modulation Type | Inhibition | ||
Cell System |
NIH 3T3 cells-MDR1 | ||||
Phosalone |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Phosalone inhibits the transportation of Verapamil by ABCB1 (IC50 = 1.5 microM) | [126] | |||
Affected Drug/Substrate |
Verapamil | Modulation Type | Inhibition | ||
Cell System |
NIH 3T3 cells-MDR1 | ||||
Propiconazole |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Propiconazole inhibits the transportation of Verapamil by ABCB1 (IC50 = 1.5 microM) | [126] | |||
Affected Drug/Substrate |
Verapamil | Modulation Type | Inhibition | ||
Cell System |
NIH 3T3 cells-MDR1 | ||||
Pyrethroids |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Pyrethroids inhibits the transportation of Verapamil by ABCB1 (IC50 = 65.5 microM) | [127] | |||
Affected Drug/Substrate |
Verapamil | Modulation Type | Inhibition | ||
Cell System |
Human embryonic kidney 293 cells (HEK293)-MDR1 | ||||
Tetramethrin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Tetramethrin inhibits the transportation of Verapamil by ABCB1 (IC50 = 100 microM) | [127] | |||
Affected Drug/Substrate |
Verapamil | Modulation Type | Inhibition | ||
Cell System |
Human embryonic kidney 293 cells (HEK293)-MDR1 | ||||
Diazinon |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Diazinon inhibits the transportation of Verapamil by ABCB1 (IC50 = 58.4 microM) | [129] | |||
Affected Drug/Substrate |
Verapamil | Modulation Type | Inhibition | ||
Cell System |
NIH 3T3 cells-MDR1 | ||||
Hypericum perforatum |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Hypericum perforatum induces the transportation of Amitriptyline by ABCB1 | [137] | |||
Affected Drug/Substrate |
Amitriptyline | Modulation Type | Inducer | ||
Cell System |
Depression patients | ||||
Glabridin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Glabridin inhibits the transportation of Daunorubicin by ABCB1 | [139] | |||
Affected Drug/Substrate |
Daunorubicin | Modulation Type | Inhibition | ||
Cell System |
Multiple drug-resistant human KB carcinoma cell line (KB-C2)-MDR1 | ||||
Glycyrrhetinic acid |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Glycyrrhetinic acid inhibits the transportation of Daunorubicin by ABCB1 | [139] | |||
Affected Drug/Substrate |
Daunorubicin | Modulation Type | Inhibition | ||
Cell System |
Multiple drug-resistant human KB carcinoma cell line (KB-C2)-MDR1 | ||||
Echinacea purpurea |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Echinacea purpurea inhibits the transportation of Digoxin by ABCB1 | [140] | |||
Affected Drug/Substrate |
Digoxin | Modulation Type | Inhibition | ||
Cell System |
Human enterocyte-like 2 cell (Caco-2)-MDR1 | ||||
Echinacea extract |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Echinacea extract inhibits the transportation of Digoxin by ABCB1 | [140] | |||
Affected Drug/Substrate |
Digoxin | Modulation Type | Inhibition | ||
Cell System |
Human enterocyte-like 2 cell (Caco-2)-MDR1 | ||||
Fructose |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Fructose inhibits the transportation of Digoxin by decreasing the expression and activity of the ABCB1 | [141] | |||
Affected Drug/Substrate |
Digoxin | Modulation Type | Inhibition | ||
Cell System |
Model organism in vivo (Male Sprague-Dawley rats) | ||||
(-)Epicatechin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
(-)Epicatechin induces the transportation of LDS-751 by ABCB1 | [142] | |||
Affected Drug/Substrate |
LDS-751 | Modulation Type | Inducer | ||
Cell System |
NIH-3T3-G185-MDR1 | ||||
Chloroacetanilides |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Chloroacetanilides inhibits the transportation of Paclitaxel by ABCB1 | [122] | |||
Affected Drug/Substrate |
Paclitaxel | Modulation Type | Inhibition | ||
Cell System |
Myelogenous leukemia cell line (K562)-MDR1 | ||||
Q-100154 |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Ginsenoside Rg3 inhibits the transportation of Rhodamine 123 by ABCB1 in a competitive manner | [144] | |||
Affected Drug/Substrate |
Rhodamine 123 | Modulation Type | Inhibition | ||
Cell System |
Multidrug-resistant human fibroblast carcinoma cell line (KBV20C)-MDR1 | ||||
Sesamin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Sesamin inhibits the transportation of Rhodamine 123 by significantly increasing the mRNA expression of ABCB1 | [145] | |||
Affected Drug/Substrate |
Rhodamine 123 | Modulation Type | Inhibition | ||
Cell System |
Human colon carcinoma LS-180 cells (LS-180V)-MDR1 | ||||
Schisandra chinensis extract |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Schisandra chinensis extract inhibits the transportation of Talinolol by ABCB1 | [146] | |||
Affected Drug/Substrate |
Talinolol | Modulation Type | Inhibition | ||
Cell System |
Healthy people | ||||
Xanthohumol |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Xanthohumol inhibits the transportation of Tetraethylammonium by ABCB1 | [147] | |||
Affected Drug/Substrate |
Tetraethylammonium | Modulation Type | Inhibition | ||
Cell System |
Human enterocyte-like 2 cell (Caco-2); LLC-PK1 vesicles | ||||
Fangchinoline |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Fangchinoline inhibits the transportation of Verapamil by ABCB1 | [148] | |||
Affected Drug/Substrate |
Verapamil | Modulation Type | Inhibition | ||
Cell System |
Human colon adenocarcinoma cell line (HCT15)-MDR1 | ||||
Tetrandine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Tetrandine inhibits the transportation of Verapamil by ABCB1 | [148] | |||
Affected Drug/Substrate |
Verapamil | Modulation Type | Inhibition | ||
Cell System |
Human colon adenocarcinoma cell line (HCT15)-MDR1 | ||||
Ginseng extract |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Ginseng extracts inhibits the transportation of Verapamil by ABCB1 | [160] | |||
Affected Drug/Substrate |
Verapamil | Modulation Type | Inhibition | ||
Acteoside |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Acteoside inhibits the activity of ABCB1 | [166] | |||
Cell System |
Model organism in vivo (rat) | ||||
Agnuside |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Agnuside inhibits the activity of ABCB1 | [166] | |||
Cell System |
Model organism in vivo (rat) | ||||
Catechin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Catechin inhibits the activity of ABCB1 | [166] | |||
Cell System |
Model organism in vivo (rat) | ||||
Negundoside |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Negundoside induces the activity of ABCB1 | [166] | |||
Cell System |
Model organism in vivo (rat) | ||||
Oleanolic acid |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Oleanolic acid induces the activity of ABCB1 | [166] | |||
Cell System |
Model organism in vivo (rat) | ||||
Picroside-I |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Picroside-I induces the activity of ABCB1 | [166] | |||
Cell System |
Model organism in vivo (rat) | ||||
Picroside-II |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Picroside-II inhibits the activity of ABCB1 | [166] | |||
Cell System |
Model organism in vivo (rat) | ||||
Piperine (high concentration) |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Piperine (high concentration) inhibits the activity of ABCB1 | [166] | |||
Cell System |
Model organism in vivo (rat) | ||||
Santonin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Santonin inhibits the activity of ABCB1 | [166] | |||
Cell System |
Model organism in vivo (rat) | ||||
Echinacea pallida roots extract |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Echinacea pallida roots extract inhibits the activity of ABCB1 | [167] | |||
Cell System |
Human proximal tubule HK-2 cell line (HK-2)-MDR1 | ||||
Nobiletin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Nobiletin inhibits the activity of ABCB1 | [168] | |||
Cell System |
Model organism in vivo (rat) | ||||
Rutin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Rutin inhibits the activity of ABCB1 | [168] | |||
Cell System |
Model organism in vivo (rat) | ||||
Tangeretin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Tangeretin inhibits the activity of ABCB1 | [168] | |||
Cell System |
Model organism in vivo (rat) | ||||
Protopanaxatriol ginsenoside |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Protopanaxatriol ginsenoside inhibits the activity of ABCB1 | [169] | |||
Cell System |
Doxorubicin-resistant Acute myelogenous leukemia cell line (AML-2/D100)-MDR1 | ||||
Cyanidin-3-rutinoside |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Cyanidin-3-rutinoside inhibits the activity of ABCB1 | [170] | |||
Cell System |
Human breast adenocarcinoma cell line (MCF-7)-BSEP | ||||
Delphinidin-3-Glucoside |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Delphinidin-3-Glucoside inhibits the activity of ABCB1 | [170] | |||
Cell System |
Human breast adenocarcinoma cell line (MCF-7)-BSEP | ||||
Malvidin-3-galactoside |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Malvidin-3-galactoside inhibits the activity of ABCB1 | [170] | |||
Cell System |
Human breast adenocarcinoma cell line (MCF-7)-BSEP | ||||
Malvidin-3-glucoside |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Malvidin-3-glucoside inhibits the activity of ABCB1 | [170] | |||
Cell System |
Human breast adenocarcinoma cell line (MCF-7)-BSEP | ||||
Pelargonidin-3,5-diglucoside |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Pelargonidin-3,5-diglucoside inhibits the activity of ABCB1 | [170] | |||
Cell System |
Human breast adenocarcinoma cell line (MCF-7)-BSEP | ||||
Tetrahydrocurcumin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Tetrahydrocurcumin inhibits the activity of ABCB1 | [171] | |||
Cell System |
Multidrug-resistant subclone KB-V-1 cells | ||||
Ginkgolide B |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Ginkgolide B increases the expression of ABCB1 | [272] | |||
Regulation Mechanism |
via enhancement of Nuclear receptor subfamily 1 group I member 2 (NR1I2) | Transcription Factor Info | |||
Cell System |
Human umbilical vein endothelial cells (HUVECs) | ||||
Tamarixetin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Tamarixetin increases the expression of ABCB1 | [273] | |||
Regulation Mechanism |
via enhancement of Nuclear receptor subfamily 1 group I member 2 (NR1I2) | Transcription Factor Info | |||
Cell System |
Human colon adenocarcinoma cells (LS180) | ||||
6-bromoindirubin-3'-oxime |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
6-bromoindirubin-3'-oxime increases the expression of ABCB1 | [289] | |||
Bergamottin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Bergamottin increases the expression of ABCB1 | [291] | |||
Chrysin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Chrysin inhibits the activity of ABCB1 | [297] | |||
Gallic Acid |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Gallic Acid inhibits the expression of ABCB1 | [298] | |||
Mangiferin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Mangiferin increases the expression of ABCB1 | [298] | |||
Notoginsenoside R1 |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Notoginsenoside R1 increases the expression of ABCB1 | [308] | |||
Clove Oil |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Clove Oil increases the expression of ABCB1 | [319] | |||
Lemongrass oil |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Lemongrass oil increases the expression of ABCB1 | [319] | |||
Peppermint oil |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Peppermint oil increases the expression of ABCB1 | [319] | |||
Flavone |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Flavone inhibits the expression of ABCB1 | [327] | |||
Thapsigargin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Thapsigargin inhibits the expression of ABCB1 | [328] | |||
Rhein |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Rhein inhibits the expression of ABCB1 | [339] | |||
Regulation Mechanism |
via the inhibition of Signal transducer and activator of transcription 3 (STAT3) | Transcription Factor Info | |||
Affected Drug/Substrate |
Doxorubicin | Modulation Type | Inhibition | ||
Cell System |
Human cervical epithelioid carcinoma cells (HeLaS3) | ||||
Plant Extract |
|||||
Mangifera indica extract |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Mangifera indica extract inhibits the expression of ABCB1 | [298] | |||
Basil oil |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Basil oil increases the expression of ABCB1 | [319] | |||
Caraway oil |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Caraway oil increases the expression of ABCB1 | [319] | |||
Cinnamon oil, bark |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Cinnamon oil, bark increases the expression of ABCB1 | [319] | |||
Coriander oil |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Coriander oil increases the expression of ABCB1 | [319] | |||
Juniper berry oil |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Juniper berry oil increases the expression of ABCB1 | [319] | |||
Plant Extracts |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Plant Extracts inhibits the activity of ABCB1 | [167] | |||
Dietary Constituent |
|||||
Grapefruit juice |
5 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Grapefruit juice inhibits the transportation of Digoxin by ABCB1 | [62] | |||
Affected Drug/Substrate |
Digoxin | Modulation Type | Inhibition | ||
Cell System |
Human enterocyte-like 2 cell (Caco-2)-MDR1 | ||||
DT Modulation 2 |
Grapefruit juice peel inhibits the transportation of Digoxin by ABCB1 | [62] | |||
Affected Drug/Substrate |
Digoxin | Modulation Type | Inhibition | ||
Cell System |
Human enterocyte-like 2 cell (Caco-2)-MDR1 | ||||
DT Modulation 3 |
Grapefruit juices induces the transportation of Fexofenadine by ABCB1 | [62] | |||
Affected Drug/Substrate |
Fexofenadine | Modulation Type | Inducer | ||
Cell System |
Transfected cell lines-MDR1 | ||||
DT Modulation 4 |
Grapefruit juices inhibits the transportation of Talinolol by ABCB1 | [63] | |||
Affected Drug/Substrate |
Talinolol | Modulation Type | Inhibition | ||
Cell System |
Human enterocyte-like 2 cell (Caco-2)-MDR1 | ||||
DT Modulation 5 |
Grapefruit juice induces the activity of ABCB1 | [67] | |||
Cell System |
Madin darby canine kidney strain cell line (MDCK)-MDR1 | ||||
Environmental toxicant |
|||||
o,p'-dichlorodiphenyltrichloroethane (DDT) |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
O,p'-DDT inhibits the transportation of Verapamil by ABCB1 (IC50 = 7.8 microM) | [128] | |||
Affected Drug/Substrate |
Verapamil | Modulation Type | Inhibition | ||
Cell System |
Spodoptera frugiperda (Sf9) cells-MDR1 | ||||
p,p'-dichlorodiphenyltrichloroethane (DDT) |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
p,p'-DDT inhibits the transportation of Verapamil by ABCB1 (IC50 = 3.8 microM) | [128] | |||
Affected Drug/Substrate |
Verapamil | Modulation Type | Inhibition | ||
Cell System |
Spodoptera frugiperda (Sf9) cells-MDR1 | ||||
p,p'-tetrachlorodiphenylethane (DDD) |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
p,p'-DDD inhibits the transportation of Verapamil by ABCB1 (IC50 = 10.7 microM) | [128] | |||
Affected Drug/Substrate |
Verapamil | Modulation Type | Inhibition | ||
Cell System |
Spodoptera frugiperda (Sf9) cells-MDR1 | ||||
p,p'-dichlorodiphenyldichloroethane (DDE) |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
p,p'-DDE inhibits the transportation of Verapamil by ABCB1 | [128] | |||
Affected Drug/Substrate |
Verapamil | Modulation Type | Inhibition | ||
Cell System |
Spodoptera frugiperda (Sf9) cells-MDR1 | ||||
Polychlorinated dibenzodioxin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Polychlorinated dibenzodioxin increases the expression of ABCB1 | [271] | |||
Regulation Mechanism |
via enhancement of Aryl hydrocarbon receptor (AHR) | Transcription Factor Info | |||
Cell System |
Killifish renal proximal tubule cells | ||||
Dichlorodiphenyl Dichloroethylene |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Dichlorodiphenyl Dichloroethylene inhibits the expression of ABCB1 | [285] | |||
Tetrabromobisphenol A |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Tetrabromobisphenol A inhibits the activity of ABCB1 | [305] | |||
Pharmaceutical excipient |
|||||
PEG 300 |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
PEG 300 inhibits the transportation of Ranitidine by ABCB1 | [143] | |||
Affected Drug/Substrate |
Ranitidine | Modulation Type | Inhibition | ||
Cell System |
Human enterocyte-like 2 cell (Caco-2)-MDR1 | ||||
PEG 400 |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
PEG 400 inhibits the transportation of Ranitidine by ABCB1 | [143] | |||
Affected Drug/Substrate |
Ranitidine | Modulation Type | Inhibition | ||
Cell System |
Human enterocyte-like 2 cell (Caco-2)-MDR1 | ||||
Mycotoxins |
|||||
Aflatoxin B1 |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Aflatoxin B1 increases the expression of ABCB1 | [313] | |||
Acute Toxic Substance |
|||||
Indole |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Indole increases the expression of ABCB1 | [276] | |||
Regulation Mechanism |
via enhancement of Nuclear receptor subfamily 1 group I member 2 (NR1I2) | Transcription Factor Info | |||
Cell System |
Human Caucasian colon adenocarcinoma cells (LS180) | ||||
Chlorpyrifos |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Chlorpyrifos increases the expression of ABCB1 | [277] | |||
Regulation Mechanism |
via enhancement of Nuclear receptor subfamily 1 group I member 2 (NR1I2) | Transcription Factor Info | |||
Cell System |
Rainbow trout intestine isolates | ||||
Cycloheximide |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Cycloheximide increases the expression of ABCB1 | [256] | |||
Sarin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Sarin inhibits the expression of ABCB1 | [294] | |||
Avermectin B1a |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Avermectin B1a inhibits the activity of ABCB1 | [205] | |||
Formaldehyde |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Formaldehyde increases the expression of ABCB1 | [314] | |||
Sinensetin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Sinensetin inhibits the activity of ABCB1 | [320] | |||
Okadaic Acid |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Okadaic Acid increases the expression of ABCB1 | [323] | |||
Acrylamide |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Acrylamide increases the expression of ABCB1 | [325] | |||
Morin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Morin increases the activity of ABCB1 | [327] | |||
Carcinogen |
|||||
2-acetylaminofluorene |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
2-acetylaminofluorene inhibits the expression of ABCB1 | [26] | |||
Benzo(a)pyrene |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Benzo(a)pyrene increases the expression of ABCB1 | [332] | |||
Fungicide |
|||||
Triadimefon |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Triadimefon increases the expression of ABCB1 | [292] | |||
Pesticide/Insecticide |
|||||
Fenvalerate |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Fenvalerate inhibits the activity of ABCB1 | [129] | |||
Dieldrin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Dieldrin increases the expression of ABCB1 | [124] | |||
Heptachlor |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Heptachlor increases the expression of ABCB1 | [124] | |||
Dicrotophos |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Dicrotophos inhibits the expression of ABCB1 | [315] | |||
Health and Environmental Toxicant |
|||||
Isosafrole |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Isosafrole increases the expression of ABCB1 | [75] | |||
Diethylhexyl Phthalate |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Diethylhexyl Phthalate increases the expression of ABCB1 | [288] | |||
Lithium Chloride |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Lithium Chloride increases the expression of ABCB1 | [289] | |||
Perfluorooctane sulfonic acid |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Perfluorooctane sulfonic acid inhibits the activity of ABCB1 | [305] | |||
Chlordan |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Chlordan increases the expression of ABCB1 | [124] | |||
Butyraldehyde |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Butyraldehyde increases the expression of ABCB1 | [310] | |||
tris(1,3-dichloro-2-propyl)phosphate |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
tris(1,3-dichloro-2-propyl)phosphate increases the expression of ABCB1 | [311] | |||
2-methylindole |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
2-methylindole increases the expression of ABCB1 | [324] | |||
3-methylquercetin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
3-methylquercetin inhibits the expression of ABCB1 | [327] | |||
Herbicide |
|||||
metolachlor |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
metolachlor increases the activity of ABCB1 | [122] | |||
Peptide |
|||||
Carbon Tetrachloride |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Carbon Tetrachloride increases the expression of ABCB1 | [283] | |||
Chemical Compound |
|||||
Naphthalene |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Naphthalene inhibits the activity of ABCB1 | [290] | |||
7-methylindole |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
7-methylindole increases the expression of ABCB1 | [324] | |||
Gold |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Gold increases the expression of ABCB1 | [331] | |||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.